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 ABSTRACT  
Obesity a low grade chronic inflammatory disease with excess storage of adipose tissue, 
energy imbalance being the prime factor for pathogenesis of obesity through oxidative 
stress which results in long term complications such as type 2 diabetes mellitus, 
cardiovascular diseases, hypertension, arthritis, cancer.  
Objective :  
To evaluate the change in the anthropometric measurements after the classical 
acupuncture.  
Methods :  
This study was conducted on 30 adults between the age of 18 - 35 years not under any 
medication and fulfilling the inclusion criteria of this study. The study design is 
experimental pre post study, Acupuncture given to the recruited subjects thrice a week, 
up to 90 days; parameters were recorded primarily at the baseline, finally at the end were 
compared and evaluated at the end of the study.  
Result :  
Results of this study showed that a significant reduction in (P < 0.001) on the 
anthropometric measurements significant reduction of (P = 0.05) in Weight from 
68.90±5.70 to 61.83±6.60, (P = 0.02) in BMI from 31.50±2.66 to 28.56±4.20,(P = 0.04) 
in HC from 98.24±7.86 to 96.29±5.50, (P = 0.04) in WC from 85.60±3.34 to  
  
81.06±2.90,(P = 0.12) in WHR from 0.86±0.23 to 0.83±0.12, (P = 0.01) in Total score 
from 12.60±2.56 to 3.40±5.28.  
R statistical software free version3.2.0 and paired T test were used for data analysis.  
Conclusion :  
The present study demonstrated the efficacy of classical acupuncture over obese 
individuals with spleen energy deficiency, influencing positively through reduction in 
weight, BMI, Waist circumference and Waist Hip Ratio.  
Key words: Acupuncture, Obesity, Spleen Energy deficiency, BMI, Waist 
Circumference 
 
 
 
 
 
1 
 
INTRODUCTION 
Obesity, the most prevalent non-communicable diseases and a major concern for public 
health  worldwide, mainly due to its well-established relationship with alterations, such 
as insulin resistance and  diabetes, atherosclerosis, hypertension, or some types of 
cancer, among others. Obesity, like those chronic diseases mentioned earlier, presents 
an inflammatory component. Indeed, it is now widely agreed that obesity  is  also a state 
of low-grade chronic inflammation [1.2] 
According to WHO “Obesity is defined as the excessive amount of fat in the body” 
.Obesity is determined through the anthropometric measurements which is calculated by 
body mass index [BMI]., measured by  height in  m2 and weight in kg [3]. 
In accordance with WHO  prevalence of obesity in world statistics report took on 2012 
in which one in six adults are obese individuals. Currently, over a billion people are 
overweight and half a billion are obese.  
In INDIA, the prevalence of obesity is about 132 millions individuals.  
In TAMILNADU, about 24.6% among residents are obese [4]. 
The fundamental cause of obesity and overweight is an energy imbalance between 
calories consumed and calories expended. Globally, there has been: an increased intake 
of energy-dense foods that are high in fat; and an increase in physical inactivity due to 
the increasingly sedentary nature of many forms of work,  
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changing modes of transportation, and increasing urbanization. Changes in dietary and 
physical activity patterns are often the result of environmental and societal changes  
associated with development and lack of supportive policies in sectors such as health, 
agriculture, transport,  urban planning, environment, food processing, distribution, 
marketing, and education. 
Raised BMI is a major risk factor for noncommunicable diseases such as: 
cardiovascular diseases [mainly heart disease and stroke]., which were the leading cause 
of death in  2012; diabetes;  musculoskeletal disorders [especially osteoarthritis – a 
highly disabling degenerative disease of the  joints].;  some cancers [including 
endometrial, breast, ovarian, prostate, liver, gallbladder, kidney, and  colon]. The risk 
for these noncommunicable diseases increases, with increases in BMI.  
Obesity is a chronic and multi-factorial disease and one of the most important causes of 
morbidity and premature mortality worldwide. Non-surgical and non 
pharmacotherapeutical treatment options include diet,  exercise, behaviour modification 
and psychological support. The effect size has been reported with  a single  digit weight 
loss in kilograms which can be maintained [5]. 
Being one a mong  the  most  effective modalities in Complementary and 
AlternativeMedicine, Acupuncture  harmonizes energy flow inside the human body 
which leads to optimal physiological  functions through its   positive  influence over  the 
HPA axis by  reestablishing the balance between Sympathetic and  Parasympathetic  
Nervous system [6,7,8]. 
3 
 
Obesity was first mentioned in Chinese medicine in the Yellow Emperor’s Internal 
Classic of Medicine: 
"When treating exhaustion syndromes, sudden syncope, hemiplegia, atrophy, or rapid 
respiration conditions that occur in obese patients, recognize that these are usually due 
to overindulgence in rich foods"[9]. 
The etiology and pathogenesis of obesity in Chinese medicine has four main factors. 
They include"righteous qi deficiency, improper diet, lack of physical exercise, and 
constitutional factors." [8].   
Deficiency of righteous qi has many reasons. The result however is damage to the 
spleen energy. The spleen energy is in charge of transportation and transformation. 
When there is a dysfunction of the spleen energy there will be an accumulation of 
dampness and phlegm causing weight gain. Improper diet can also injure the spleen 
energy and stomach energy. When an individual eats too much greasy and rich foods 
overtime it will injure the spleen energy and stomach energy. The result of eating too 
much greasy foods will be an accumulation of damp-heat and phlegm. Lack of physical 
exercise can cause poor circulation within the body. Qi and blood are not able to flow in 
the body causing stagnation. The stagnation of fluids in the body can result into 
dampness and fat. Constitutional factors were noted in the Internal Classics. The 
physical appearance of being overweight can be inherited from parents and past 
generations [10]. 
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The main factors that cause obesity in Chinese medicine is phlegm and dampness [10]. 
Bob Flaws noted that fat in Chinese medicine is phlegm and dampness[16]. Because 
phlegm and dampness is the major contributor to fat in Chinese medicine, the spleen 
energy is the major organ because of the spleen’s physiological function.However, there 
is also another factor that may cause obesity is qi and blood stagnation [10]. 
PATTERN DIFFERENTIATION 
 Obesity and overweight in Chinese medicine is based on differentiation of syndromes. 
Although the main cause of obesity is phlegm and dampness there will be 
accompanying symptoms that will help differentiate  obesity according to each 
individual’s constitution. The main differentiation of syndromes for obesity are  spleen 
energy deficiency with dampness accumulation, hyperactive stomach with hypoactive 
spleen, phlegm- dampness obstruction in the middle burner, qi stagnation and blood 
stasis, and spleen and kidney yang  deficiency. 
Obesity due to spleen energy deficiency with dampness occurs because the spleen is not 
able to transport and transform resulting in accumulation of dampness which will cause 
obesity. The accompanying symptoms include obesity or overweight with edema, 
heaviness of extremities, fatigue, abdominal distention, poor appetite, loose stool, pale 
and swollen tongue with soft thready or slippery pulse [10]. 
The Internal Classic says the same about abdominal obesity as what modern medicine 
describes [11].TCM therapy holds that phlegm dampness produced by deficiency of the 
spleen energy and accumulation of body fluid is  an  important pathological factor in 
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obesity. The failure of the spleen to transport and transform nutrients can cause  
stagnation of water to produce dampness and phlegm, giving  rise to symptoms of 
obesity. The pathological nature of obesity mainly manifests as deficiency in origin and 
excess in superficiality, and  obesity is first caused  by spleen energy deficiency. 
Acupuncture used to treat obesity is safe, effective, and non-toxic. In a study on using 
acupuncture to treat obesity, Xu [12] found that acupuncture can strengthen the function 
of sympathetic nerves, inhibit overactive parasympathetic nerves, regulate the function 
of vegetative nerves, and effectively enhance the basal metabolic  rate and the level of 
endocrine hormones. These changes can increase the consumption of energy and 
promote lipodieresis. 
Acupuncture also can improve appetite, intestinal motility, metabolism, as well as 
emotional factors such as stress. Further, researches show that the application of 
acupuncture can cause increases in neural activity associated with the ventromedial 
nuclei of the hypothalamus, the tone of the smooth muscle of the stomach and levels of 
enkephalin, b-endorphin and serotonin in plasma and brain tissue.[13,14]. 
Though  previously  many studies had been done to reveal the efficacy of acupuncture 
in weight management,it is  yet to explore the efficacy of  classical acupunture approach  
over obesity caused by  spleen deficiency as per  TCM. 
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AIMS AND OBJECTIVES 
AIM: 
To evaluate the change in the anthropometric measures after the classical acupuncture. 
OBJECTIVES: 
PRIMARY OBJECTIVE: 
To evaluate the changes in anthropometric measurements. 
SECONDARY OBJECTIVE: 
To assess the changes present in spleen energy deficiency using specific scoring pattern. 
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REVIEW OF LITERATURE 
Obesity is a chronic disease that is increasing in prevalence since 1980 in the United 
States and other parts of Western World. It poses a serious risk for the development of 
diabetes mellitus along with insulin resistance, cardiovascular disease, non-alcoholic 
fatty liver disease, endocrine problems, and certain forms of cancer, modestly increasing 
the risk of overall mortality. Obesity varies by age and sex, and by race-ethnic group. 
The most widely used formula for relating the height and weight of an individual is 
body mass index (BMI). BMI is defined as a ratio of weight (kilograms) and height2 
(squaremeters) [15] . 
A BMI between 20-25 kg/m2 is normal and associated with lowest mortality, whereas a 
BMI of 25-30 kg/m2 is considered overweight.  
In adults a BMI above 30-40 kg/m2 is defined as obesity and BMI above 40 kg/m2 is 
severe obesity.  
Among the children and adolescent population with a BMI above the 95th percentile for 
age belong to the obese group [16]. However, BMI does not discriminate between muscle 
and adipose tissue and does not directly assess regional adiposity [17]. Still, BMI 
primarily due to its simplicity often serves a guide in treatment selection. 
Obesity relates to the molecular regulation of appetite that affects energy homeostasis, 
particularly as positive energy balance upsets lipid and glucose metabolism.[18,19]  
 
8 
 
Obesity appears to play a central role in the dysregulation of cellular metabolism that 
accounts for insulin  resistance in diabetes mellitus type 2.Excess  adipocytes secrete 
numerous cytokines that contribute to  vascular dysfunction in hypertension and 
dyslipidemia, as manifested by hypercholesterolemia and  triglyceridemia.These  
conditions eventually contribute to significant  atherosclerosis, and when  associated 
with obesity and/or diabetes  and insulin resistance, they constitute the metabolic  
syndrome.[20,21]. New knowledge related to fatty liver and its association with 
inflammation, as well as   visceral adiposity’s effect on gastroesophageal reflux, 
gallstone disease, and cancer of the bowel, also make the liver and gut vulnerable to 
comorbidities of obesity.[21-24] 
FACTORS CONTRIBUTING TO THE DEVELOPMENT OF OBESITY 
The etiology of obesity is multifactorial, involving complex interactions among the 
genetic background, hormones and different social and environmental factors, such as 
sedentary lifestyle and unhealthy dietary habits [25]. Table .1 lists the key factors that 
might promote or protect against weight gain and obesity as suggested by the WHO [26].  
GENETICS AND OBESITY 
Genetic determinants can either play a major role in the pathogenesis of obesity or 
enhance susceptibility to its development. The dysmorphic forms of obesity in which 
genetics play a major role include the Prader-Willi syndrome, Ahlstrom’s syndrome, the 
Laurence-Moon-Biedl syndrome,  
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TABLE.1. KEY FACTORS THAT MIGHT PROMOTE OR PROTECT 
AGAINST WEIGHT GAIN AND OBESITY AS SUGGESTED BY THE WHO 
Summary of strength of evidence on 
factors that might promote or protect 
against weight gain and obesity. 
Strength of evidence 
Decreased risk Increased risk 
Convincing Regular physical activity Sedentary lifestyle 
High dietary intake of fiber High intake of energy-dense foods 
Probable Home and school environments 
that support healthy food choices 
for children  
Breastfeeding 
Adverse socioeconomic 
conditions in developed 
countries 
Possible Low glycemic index foods Large portion sizes 
High proportion of food prepared outside the home (developed 
countries) 
 
Rigid restraint/periodic disinhibition eating patterns  
Insufficient Increased eating frequency Alcohol 
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Cohen’s syndrome and Carpenter’s syndrome [27].  Reportedly, 244 genes, when 
mutated in the mouse, result in an obese phenotype. A growing number of studies 
indicate associations between DNA sequence variation in specific genes and the 
occurrence of obesity.  
Interestingly, the involvement of 22 such genes was reported in at least five separate 
studies. The obesity gene map shows putative loci on all chromosomes except Y [28]. 
In the ob/ob mice both copies of the leptin gene are defective resulting in truncated 
protein. Unlike in humans, treatment of obese mice with leptin reduces both food intake 
and body fat. Splicing defects on the leptin receptor are responsible for the obesity in 
the db/db mouse, which is phenotypically similar to  the ob/ob mouse. The gene defect 
called tub results in a defective phosphatase and causes retinitis pigmentosa and obesity 
in mice, making it similar to the Laurence-Moon-Biedl syndrome in humans [27]. 
Linkage of human obesity to other factors related to energy balance has been reported. 
For instance, the Trp/64/Arg mutation of the human β3 adrenergic receptor (β3AR) 
gene is associated with an earlier age of onset of NIDDM and characteristics of insulin 
resistance as well as weight gain in patients with morbid obesity.  However, such 
findings have not been consistent in different ethnic populations [29]. It has been reported 
that plasma IL-8 levels are increased in obese subjects. IL-8 is related to fat mass and 
TNF system. 
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Elevated circulating IL-8 could be one of the factors that link obesity to greater 
cardiovascular risks [30].  Most of genomic studies in humans, demonstrated substantial 
genetic heterogeneity influencing BMI regulation [31]. 
ENVIRONMENTAL FACTORS AND OBESITY 
 Environmental factors interact with genetic susceptibility in the pathogenesis of 
obesity. For example, hypothalamic injury from trauma or surgery and destructive 
lesions in the region of the ventromedial or the paraventricular nuclei can produce 
obesity. The two major factors in hypothalamic obesity are hyperphagia and a 
disturbance in the ANS activity. 
One explanation for this is altered secretion of NPY, which is produced in arcuate 
nucleus and stimulates eating [32]. Other possible explanations are impairment in 
reproductive function, decrease in sympathetic and increase in parasympathetic activity 
– other key features of hypothalamic obesity [33]. Endocrine disorders such as Cushing’s 
disease, polycystic ovary syndrome and administration of some drugs (phenothiazines; 
such as chlorpromazine, antidepressants; amitriptyline, antiepileptics; valproate, 
steroids; glucocorticoids, antihypertensive agents; terazosin) may be associated with 
obesity [34, 35]. 
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FOOD INTAKE AND OBESITY 
A typical obese subject has usually put on 20 kg over 10 years. This means that there 
has been a daily excess of energy input over output of 30-40 kcal initially, increasing 
gradually to maintain the increased body weight. The type of food eaten can play a role 
in disturbing the energy balance.Fat has more calories per gram compared to 
carbohydrates or proteins. There are 9 calories per gram of dietary fat, whereas caloric 
value of carbohydrates and proteins is only 4 calories. It is possible that the mechanisms 
regulating appetite react more slowly to fat than to protein and carbohydrate, so satiety  
system come into the picture too late. Increase in density of foods, portion size, better 
palatability of food, increase in availability and low cost promote obesity [36]. 
Obese people try to diet to lose weight. But when a subject reduces calorie intake, there 
is a shift into negative energy balance. An individual loses weight but, in parallel, the 
resting metabolic rate decreases, and there is a concomitant reduction in energy 
expenditure. Probably, the system is trying to return the body weight to the “set- point 
A”, which implies maintenance of energy balance is dependent on numerous metabolic 
feedback loops that  are tuned by an individual’s susceptibility genes. Thus, an 
individual who was previously obese and is now of normal weight, generally needs 
fewer calories for maintaining that weight than an individual who has never been obese. 
The decrease in energy expenditure appears to be largely due to an alteration in the 
conversion efficiency of chemical energy to mechanical work in skeletal muscle. This 
adaptation to the caloric restriction contributes to the difficulty of maintaining weight 
loss by diet  [37]. 
13 
 
PHYSICAL ACTIVITY AND OBESITY 
Physical activity can be broadly divided into exercise and non-exercise activities. Non-
exercise activities include employment related work and the activity of daily living. It is 
difficult to measure the energy expended in non- exercise activity. In general, an 
increase in sedentary behavior and decrease in activity of daily living and  employment 
physical activity promotes obesity [38]. It is now recognized that increased energy 
expenditure by  physical activity has a more positive role in reducing fat stores and  
adjusting energy balance in the obese, especially when it is combined with modification 
of the diet.  
Native population study gives an example. Many years ago, a tribe of Pima Indians was 
divided into two groups: one of them settled in Mexico and continued with  simple life, 
eating frugally and spending most  of time in hard physical work. They are usually lean 
and have low incidence of NIDDM. Another group moved to the USA – an 
environment with easy access to calorie rich food and less need for hard physical  work. 
They are on average 57 pounds heavier than the Mexican group and have a higher 
incidence of  early onset NIDDM [39,40]. 
ENERGY BALANCE IN THE BODY 
Fat accounts for 21-37 % of the body weight of middle aged men and women. In case of 
obese individual  more calories are consumed than expended and appetite does not 
subsequently reduced to compensate for  the increase  in energy stores (Fig. 1). The 
amount of the adipose tissue is tightly regulated through neural  and humoral  signals 
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transmitted to the brain. Failure of fat cells to send adequate signals or failure of the 
brain to respond to appropriate signals causes obesity [41]. An effective system for the 
regulation of  energy balance require sensors  of energy stores in adipose tissue, 
mechanisms of relay of information to  central control sites (hypothalamus) for  
subsequent integration, which in turn will determine food intake  and energy 
expenditure [42]. 
Food intake is regulated by at least four processes: olfactory and gustatory factors, 
gastrointestinal distension,  release of gastrointestinal hormones such as insulin, 
cholecystokinin (CCK) and gastrin-releasing peptide and  activation of thermogenic 
components of the efferent sympathetic nervous system  (SNS) [43,44]. 
 
  
Fig. (1). Energy balance and etiology of obesity. 
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Energy balance is determined by the interplay between food intake, energy expenditure 
and energy storage. Obesity is a multifactorial disorder resulting from combination of 
several environmental and genetic factors. Reduction in physical activity, metabolic rate 
and thermogenesis eventually decrease energy expenditure leading to increased energy 
storage and obesity.  
Availability of palatable food as well as hypothalamic injury and different drugs 
stimulate food intake. A  growing list of genetic factors including dysmorphic 
syndromes, leptin/receptor mutation, β3AR mutation and  overexpression of NPY  
contribute to development of obesity. 
Energy expenditure is determined by physical activity, metabolic rate and 
thermogenesis. The metabolic side of energy expenditure includes cardio-respiratory 
work, the maintenance of ion gradients and  various enzymatic  activities. 
Physical activity increases energy expenditure by work of the skeletal muscle in 
addition to all above-mentioned factors. The SNS affects not only skeletal muscle and 
cardiovascular system but also thermogenesis [45]. Brown fat is specialized in adaptive 
thermogenesis. Its thermogenic capacity is possible through the expression of the 
uncoupling protein-1 (UCP-1), which uncouples oxidative phosphorylation from 
electron transport through mitochondrial respiratory chain [46]. Brown fat cells  
are rich in mitochondria, and produce more heat and less  ATP than white fat cells. 
UCP-2 occurs in both brown and white fat and is upregulated if mice are fed a high-fat 
diet. In humans, fat cells express the product of a gene similar to the mouse gene for 
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UCP-2. Infants and children have much more brown fat than adults, it has extensive 
sympathetic innervations. Heat is produced through the action of noradrenalin on β3AR 
in brown fat. Activation of β3AR increases lipolysis and fatty acid oxidation. 
Interestingly, in genetically obese mice the expression of β3AR s is decreased [45]. 
ADIPOSE TISSUE AND ITS PHYSIOLOGY 
PHYSIOLOGICAL FEATURES OF WHITE ADIPOSE TISSUE 
INNERVATIONS 
The fat cell is under multiple influences, including that of autonomous nervous system 
(Fig. 2), local blood flow changes and various hormones and factors delivered from 
plasma or produced locally.  
Adipose tissue secretes leptin in states of food deprivation, SNS stimulation, exercise 
and cold exposure.  
Leptin secretion from adipose tissue is inhibited by obesity states, glucocorticoids, 
glucose and insulin.  Leptin reaches hypothalamus, where in turn it inhibits secretion of 
NPY that normally reduces energy expenditure, enhancesappetite and stimulates 
synthesis and storage of fat.  
Adiponectin normally sensitizes tissues for insulin effects. Obesity and insulin  
resistance negatively regulate adiponectin  secretion from adipose tissue, whereas 
weight reduction enhances its  secretion. 
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Figure (2). Physiologic regulation and metabolic effects of leptin and adiponectin. 
Following SNS stimulation, noradrenaline and NPY are released from sympathetic 
nerve terminals, whereas adrenal medulla secretes adrenaline. The major pathways 
regulating lipolysis are adrenergic. In  human fat cells, both β1& β2 AR adrenergic 
receptors (ARs) initiate activation of lipolytic cascade by stimulation of  cyclic 
adenosine monophosphate (cAMP) production, activation of cAMP-dependent  protein 
kinase A (PKA) leading to phosphorylation of perilipin and hormone-sensitive lipase 
(HSL), and  promotion of lipolysis in vitro  [47]. Human fat cells express large number of 
2 adrenergic receptors, their stimulation inhibits cAMP production and lipolysis. 
Rodents possess β3AR in the white fat cells, whereas in human fat cells the role of the 
β3AR s is unclear.  
Differences exist in the adrenergic regulation of lipolysis in adipose tissues from 
different sites in normal-weight subjects and in obese subjects. The lipolytic response of 
isolated fat cells to the catecholamines is weaker in   subcutaneous (abdominal/femoral) 
than in visceral adipose tissue [48].  
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One possible explanation includes   defective signaling pathways such as reduced β1& 
β2 AR adrenergic receptors (ARs) or increased β 2 AR responsiveness.  Alterations in 
expression and function of HSL or other interacting proteins like adipocyte lipid-
binding protein (ALBP) may also explain these site-related regional differences in 
lipolysis [49]. Reduced lipid mobilization occurs during exercise in subcutaneous fat of 
obese subjects [50]. Functional changes in 2 β1& β2 AR adrenergic receptors (ARs) 
balances appear with the extent of the fat mass and are related to fat cell hypertrophy. 
Hypertrophic subcutaneous fat cells (abdominal, femoral) are least responsive to the 
lipolytic action of catecholamins; they exhibit the highest amount of β2 ARs and the 
lowest amount of β1& β2 AR adrenergic receptors (ARs) 
Increased expression of the former with concomitant decrease of the latter in 
hypertrophied fat cell could be a physiological adaptation leading to a reduction of the 
lipolytic responsiveness of the hypertrophied adipocytes [51]. Limitation of basal and 
SNS-dependent lipolysis avoids excessive non-esterified fatty acids (NEFA)  release  
from some fat deposits.The “buffering” effect of NEFA by adipose tissue is an 
important phenomenon. When NEFA buffering capacity is inadequate, other tissues are 
exposed to elevated NEFA concentrations [52].  
Profound unresponsiveness of the subcutaneous adipose tissue to lipolysis by neural  
stimulation has been described in obese subjects [53]. β2 adrenergic mediated increases  
in thermogenesis and lipid oxidation are impaired in obese individuals [54].  
  
Polymorphisms in the coding and non-coding sequences in the human β2 
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AR gene could be of major importance for obesity, energy expenditure, and β2AR  
 
dependent   lipolytic function. Full β- adrenergic activation of the human fat cell usually  
 
requires  synergistic activation of β1& β2 AR adrenergic receptors (ARs).  AR  
 
adrenergic  receptors (ARs) – adrenergic defect could be sufficient enough to alter  
 
normal β  adrenergic responsiveness.  Besides, in human fat cell, any reduction in β2 
 
AR mediated lipolytic response disturbs  the normal functional balance existing  
 
between β2 and β2 AR mediated affects and  amplifies reduction of the lipolytic  
 
responsiveness initiated bythe physiological amines  in stressful situations [51]. 
 
INSULIN SIGNALING IN THE ADIPOCYTES 
Insulin plays a major role in the control of adipose tissue development and function. 
Insulin not only regulates lipogenesis but also the rate of lipolysis and NEFA efflux. 
Insulin controls glucose uptake and causes fatty acid transport protein translocation and 
enhanced fatty acid uptake in adipocytes [55].Insulin inhibits basal and  
catecholaminestimulated lipolysis through phosphorylation via the Ser/Thr protein  
kinase B (PKB) dependent  action and activation of type 3B phosphodiesterase (PDE-
3B), leading to a  decreased cAMP level, that prevents  HSL activation.  
Insulin-induced antilipolysis and activation of NEFA re-esterification are blunted in 
omental compared to subcutaneous fat cells. Various functional differences have been 
identified at the receptor level and the post-receptor level of insulin signaling cascade 
[56].Other substances possibly playing a role in lipolytic pathways are atrial natriuretic 
peptide (ANP), growth hormone (GH), and miscellaneous agents such as nitric oxide 
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(NO). ANP stimulation ofhuman fat cells activates cyclic GMP (cGMP)-dependent 
protein kinase (cGK-I type), which phosphorylates perilipin and HSL, thus explaining 
lipolytic action [57]. Although GH treatments in adults reduce visceral obesity and affect 
insulin sensitivity, the physiological contribution of GH to the control of human adipose 
tissue lipid mobilization remains elusive [51].  
GH dependent modification of the relationships between adenylyl cyclase and Gi2 alpha 
protein  removes inhibition of cAMP production and consequently increases lipolysis 
[58].  NO or related redox species  such as NO+/NO-  have been proposed as potential 
regulators of lipolysis in rodent  and  human fat cells [59]. Cachexia-inducing tumors 
produce a lipid-mobilizing factor (LMF), and induction of lipolysis by LMF was 
associated with increased levels of intracellular cAMP [60]. ZAG is a new adipose tissue 
protein that may be involved in the modulation of lipolysis in adipocytes. Zinc α-2-
glycoprotein (ZAG) and tumor related LMF were detected in major fat deposits in mice. 
ZAG expression and protein was also found in human fat cells [59].  
Various hormones and autacoids are known to negatively control adenylyl cyclase 
activity and inhibit cAMP production and lipolysis in fat cells. In addition, the 
stimulation of leptin secretion was observed with various agonists (A1-adenosine, 
β2AR, and NPY-Y1 receptor agonists) [51]. 
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DYSREGULATION OF LIPID AND GLUCOSE METABOLISM:  
LIPOTOXICITY AND INSULIN RESISTANCE IN OBESITY 
 
FIGURE.3.ROLE OF LIPOTOXICITY AND INFLAMMATION ON OBESITY. 
White adipose tissue (WAT) releases pre–fatty acids and adipokines, which are 
lipotoxic and inflammatory and result in diverse effects, outlined in the left-hand  
columns. Their correlation to the metabolic syndrome is shown on the right-hand 
column, whereas all the effects culminate in atherosclerosis on the bottom of the figure.  
*Perturbed glucose and lipid metabolism.  DM-2=diabetes mellitus-2; FFA=free fatty 
acids; IL=interleukin; IRS=insulin receptor substrate; NF- KB=nuclear factor kappa 
beta; NS=nervous system; PAI-1=plasminogen activator inhibitor-1; SMC=smooth 
muscle cell; TG=triglyceride;  
TNF=tumor necrosis factor. 
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The abundance of stored fat is required for survival during nutritionally deprived states 
such as starvation.  In times of prolonged abundance of food, however, very efficient fat 
storage results in the excessive storage of fat, eventually resulting in obesity [61-63].  It 
has been hypothesized that the storage of fatty acid as triacylglycerol within adipocytes 
protects against fatty acid toxicity; otherwise, free fatty acids would circulate freely in 
the vasculature and produce oxidative stress by disseminating throughout the body.  
However, the excessive storage that creates obesity eventually leads to the release of 
excessive fatty acids from enhanced lipolysis, which is stimulated by the enhanced 
sympathetic state existing in obesity. The release of these excessive free fatty acids then 
incites lipotoxicity, as lipids and their metabolites create oxidant stress to the 
endoplasmic reticulum and mitochondria. This affects adipose as well as nonadipose  
tissue, accounting for its pathophysiology in many organs, such as the liver and 
pancreas, and in the  metabolic syndrome.[64,65]. The free fatty acids released from 
excessively stored triacylglycerol deposits also inhibit lipogenesis, preventing adequate 
clearance of serum  triacylglycerol levels that  contribute to hypertriglyceridemia. 
Release of free fatty acids by endothelial lipoprotein lipase from increased serum 
triglycerides within elevated β lipoproteins causes lipotoxicity that results in insulin- 
receptor dysfunction. The consequent insulin-resistant state creates hyperglycemia with 
compensated hepatic gluconeogenesis. The latter increases hepatic glucose production, 
further accentuating the hyperglycemia caused by insulin resistance. Free fatty acids 
also decrease utilization of insulin-stimulated muscle glucose, contributing further to 
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hyperglycemia.[66,67].Lipotoxicity from excessive free fatty acids  also decreases 
secretion of pancreatic β-cell insulin, which eventually results in β-cell exhaustion [68]. 
SITES AND FUNCTION OF ADIPOKINES 
Adipocytes, consisting of over one billion cells, not only store triacylglycerol in fat 
depots in various body sites to provide energy reserves, but in aggregate constitute the 
largest endocrine tissue that constantly communicates with other tissues by adipocyte-
released secretagogues, such as the proteohormones lectin, adiponectin, and visfatin. 
Along with insulin, these proteohormones help regulate body-fat mass.[69,70] Other gene 
groups that contribute to adipocyte adipokines include cytokines,  growth factors, and 
complement proteins [70]. These  include  the inflammatory adipokines tumor necrosis 
factor (TNF)-α, interleukin (IL)-1, and IL-6 that cause  local  steatonecrosis, but are also  
distributed by the vascular system and cause inflammation elsewhere [71]. The enhanced 
fat content in muscle becomes so significant in severe obesity that whole-body magnetic  
resonance imaging reveals cumulative fat depots in muscle sites similar in size to that of 
total visceral  adipose  tissue [72].Buttock fat appears to be largely inert with respect to 
endocrine function, as this fat is used largely for long-term energy reserves[73]. Visceral 
fat depots release inflammatory adipokines, which, along with  free fatty acids,  provide 
the pathophysiologic basis for comorbid conditions associated with obesity such  as 
insulin resistance and  diabetes mellitus type 2 [74]. Visceral adipokines are transported 
by the portal vascular system to the liver, enhancing nonalcoholic steatohepatitis  
(NASH), and also by the systemic circulation to other diverse sites. Along with fatty-
acid lipotoxicity, visceral adipokines also contribute to the adipokine inflammatory 
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injury that leads to pancreatic β-cell dysfunction, which, in turn, decreases insulin 
synthesis and secretion. 
THE PHYSIOLOGY OF OBESITY 
The amount of fat in the body (adiposity) is not, as was once thought, a passive result of 
bad habits or over-indulgence. Rather, it is precisely regulated as part of the process of 
energy homeostasis, a process where by energy intake (food intake) is matched to 
energy expenditure (metabolism and exercise) and the size of the body’s energy stores 
(the fat mass). 
The major organ regulating this system is the brain, although multiple organ systems 
participate in the process gastrointestinal system to control all aspects of energy 
homeostasis. Adiposity signals are connected through central autonomic pathways to 
centres that process satiety signals. 
Reduced input from adiposity signals (eg after weight loss) increases meal size by 
reducing brain response to satiety signals. Source: Schwartz et al [75] 
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Figure .4. Pathways by which signals related to the fat mass are integrated with signals 
from the gastrointestinal system (satiety signals) to control energy homeostasis [75] 
.Adiposity signals enter the brain at the level of the hypothalamus. Neural signals from 
the gastrointestinal system and the liver provide information about the food that is being 
eaten, for example, the taste of the food, how much the stomach is distended, and the 
chemical content of the food. These satiety signals are  sent to the hindbrain. The brain 
responds to the hormone signals via integrated neuropeptide pathways, leading to a  
number of outputs that are directly related to energy homeostasis. These include: 
neuroendocrine activation from the pituitary gland; motor behaviour (eating, exercise, 
etc); autonomic activity. In recent years it has become apparent that the autonomic 
nervous system has a much greater impact than was once thought upon many 
fundamental processes of metabolism, including lipolysis, the secretion of insulin and 
glucagon from the pancreas, and glucose synthesis and secretion from the liver. It is 
important to note that, while energy expenditure tends to decrease with ageing, mainly 
because of the absence of occupational activity and extreme physical exertion, energy 
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intake does not tend to decrease to the same extent, for a number of reasons, including 
lifetime habits. Thus there is a tendency over time for the body weight to increase. 
CONTROL OF MEAL SIZE 
There is little physiological evidence that appetite and meal initiation are controlled by 
metabolic or hormonal signals, such as low blood glucose. Rather, the available 
evidence suggests that, under normal circumstances, meal initiation is based on learned 
associations, for example, habit and the social environment. Regulation therefore has to 
involve how much is eaten and there is compelling evidence that meal cessation (that is, 
meal size) is controlled by pre-absorptive gut signals. 
In recent years a mechanism for this regulation has been elucidated. As illustrated in 
Figure 2, gastrointestinal peptides provide a signal to tell the brain how much has been 
eaten, how many calories have accumulated and help to create the feeling of satiety. The 
best known of these satiety factors is cholecystokinin (CCK). A number of experiments 
have been carried out in humans in which CCK was  given  intravenously prior to a test 
meal and,  in every instance, there was a significant reduction of meal  size. An 
important aspect is that CCK is more effective in reducing meal size when the subject 
has been  given a preload, that is, when the stomach is slightly  distended, than when no 
preload is given [76].Giving CCK can therefore reduce food intake, but does endogenous 
CCK also contribute to satiety? A recent  paper  by Beglinger and colleagues3 shows 
that administration of the CCK antagonist loxiglumide  to humans  prior to a test meal 
was associated with a significant increase in the amount of food eaten. This suggests 
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that  endogenous CCK normally acts to limit meal size, as has been shown in several 
animal species. 
Although the size of individual meals can therefore be manipulated, therapies intended 
to mimic satiety mechanisms are not in themselves likely to be efficacious for weight 
loss. There are no studies in which CCK has been given on a chronic basis to humans, 
but animal studies suggest that this would probably not lead to loss of body weight. 
 
Figure .5. How satiety factors, such as cholecystokinin, control meal size. 
CONTROL OF BODY FAT 
There is strong evidence that key hormonal regulatory signals—the adiposity 
hormones—control both how much is eaten and how much energy is expended. These 
hormones circulate in the blood in direct proportion to body fat content. They enter the 
brain and act on receptors in areas of the hypothalamus known to regulate food intake 
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and energy expenditure. If weight is lost, the hormone levels fall, food intake goes up 
and energy expenditure is reduced. The opposite occurs when an individual has gained 
excess weight. Thus body weight tends to be maintained relatively constantly over time. 
HEALTH CONSEQUENCES OF OBESITY  
Numerous epidemiological studies have been conducted to show the relationship 
between excess weight, abdominal fatness and risk of a wide range of illnesses [77- 80]. 
Table.2. summarizes the approximate relative risk of physical health problems 
associated with obesity [81].  
DIABETES  
Of all physical health problems, type II diabetes has the strongest association with 
obesity. A meta-analysis examined the relative risk of incidence of various co-
morbidities related to obesity and overweight from 89 studies [77]. Elevated BMI and 
WC were significantly associated with incidence of  type II diabetes in men and  
women. Obesity, as defined by BMI, showed the strongest association with incidences 
of type II diabetes as compared to other co-morbidities. The pooled relative risks (95% 
confidence interval) across categories of BMI were 6.75 (5.55–8.19) in men and 12.41 
(9.03–17.06) in  women [77]. In the Nurses’ Health Study, which followed 78,419 
apparently healthy women for 20 years, for each 5-unit increment in BMI, the 
multivariate  relative risk (95% confidence interval) of  diabetes was 2.36 (1.83–3.04) 
for Asians, 2.21 (1.75–2.79) for  Hispanics, 1.96 (1.93–2.00) for whites, and 1.55 (1.36–
1.77) for blacks [82]. 
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TABLE.2. APPROXIMATE RELATIVE RISK OF PHYSICAL HEALTH 
PROBLEMS ASSOCIATED WITH OBESITY. 
Relative risk >3  Relative risk 2−3  Relative risk 1−2  
Type II diabetes  Coronary heart disease  Cancer  
Gallbladder disease  Hypertension  Reproductive hormone 
abnormalities  
Dyslipidemia  Osteoarthritis  Polycystic ovary syndrome  
Insulin resistance  Hyperuricemia and gout  Impaired fertility  
Breathlessness  Low back pain  
Sleep apnea  Increased risk of anesthesia 
complications  
 Fetal defects (associated with 
maternal obesity) 
 CARDIOVASCULAR DISEASES  
Obesity predisposes an individual to a number of cardiovascular risks including 
hypertension, dyslipidemia and coronary heart disease [77,83]. In the Multi-Ethnic Study 
of Atherosclerosis, which assessed the association between obesity and cardiovascular 
risk factors and subclinical vascular disease  in 6,814 persons aged 45  to 84  years, 
showed that a higher BMI was associated with more adverse levels  of blood pressure,  
lipoproteins, and  fasting glucose, and higher prevalence ratios of hypertension [84].  
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Another study in an  Asia Pacific population  reported that a one-standard deviation 
increase in index was associated with an  increase in risk of ischemic heart  disease of 
17% (95% CI 7–27%) for BMI, 27%  (95% CI 14–40%) for  WC, 10% (95% CI 1–
20%) for hip  circumference, and 36% (95% CI21–52%) for  WHR [85].  
CANCERS  
A number of reviews have considered the association of obesity and cancer [77, 86 - 88]. 
Data from a meta- analysis  showed that the pooled relative risks across categories of 
BMI for various cancers ranged  from 1.05– 2.29 in men  and 1.13−3.22 in women [77]. 
The recent report by the World Cancer Int. J.  Environ. Res. Public  Health 2010, 7 – 
771. 
Research Fund and the American Institute for Cancer Research (2007) [81] also 
suggested that there was  convincing evidence that overweight and obesity increased the 
risk of cancers of the esophagus, pancreas,  colon  and rectum, breast (postmenopausal), 
endometrium, and kidney. In addition, there was convincing   evidence to  support 
thatabdominal fatness was a cause of colon cancer and may probably increase the  risk 
of cancers of  breast (postmenopausal) and endometrium.  
OTHER HEALTH CONSEQUENCES OF OBESITY  
There is a wealth of evidence to show that excess weight is an important risk factor in 
the development of  other  illnesses, including respiratory diseases [78 ], chronic kidney 
diseases [80], musculoskeletal  disorders [89,90] gastrointestinal and hepatic disorders [91,92], 
lower physical functioning performance  [93] and psychological  problems [94].  
31 
 
CAUSES OF OBESITY FROM A TCM PERSPECTIVE 
Obesity is a relatively untouched subject, and there is only a few mentioning in the 
Inner Classic of the Yellow Emperor [1,95] , where it divides overweight patients into two 
types, depending on their bodily  proportions of fat and muscles. It mentions that both 
types are a result of overeating heavy, rich, and  sweet foods and that continuous 
consumption will lead to idiopathic thirst, urination, and eventually sudden loss of 
consciousness—currently postulated to be symptoms of  diabetes and stroke. However,  
there is not much explanation on treatment.Therefore, current day primary obesity has 
to be approached by applying basic TEAM principles of maintaining harmony  and 
balance of the five vital organs [2,96] and taking into account the consequent problems 
that may arise when such system  goes awry. 
In TEAM, the five vital organs that maintain our everyday health are the Liver [3,97] , 
Heart, Spleen, Lung, and Kidney. These fi ve work in close cooperation to maintain 
homeostasis by either supporting or hindering each other’s functions. In obesity, the 
Spleen plays a critical role, and to understand this mechanism, we have to fi rst peer into 
the digestive system. 
Once the food enters the body, the Spleen functions like the “energy/qi transformer,” or 
the “dynamo” in  a machine—to transform and collect worthy energy and essential 
materials from it.However, it needs help from another organ to do so and right below it, 
the Stomach, is the “burner”which helps to heat up and combust the food for the Spleen. 
Thus, the food that has been combusted from the Stomach is separated into either 
essential substances that are then collected by the Spleenand transported to the organs 
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and extremities or wastes—which are sent to the Small or Large Intestines for excretion. 
Next to the Spleen and Stomach, the Liver acts as a “booster” to help spread the clean 
energy absorbed by the Spleen up and outward, while the Kidney resides below the 
whole combustion site to fuel all organs fundamentally. 
Yet, this is a very idealistic case, assuming that all organs are operating in optimal 
condition. Whena person starts to gain weight in a pathological manner, the root of most 
causes arises with the defi -ciency of qi/energy in the Spleen. Deficiency of Spleen qi 
may be induced either congenitally or byactual unsparing, harmful use of the Spleen 
such as frequent binges and fasting. When our body’s“energy transformer” is weakened, 
it not only becomes difficult to garner enough energy sources for our body but it also 
becomes difficult to spread it around. Hence, the body gets congested with slowflowing 
traffic, and just like today’s traffic congestion, all the essential substances get crammed 
failingto reach the place of its destination on time. The body will feel heavy and react 
like there is not enough energy, which is why most overweight people tend to feel more 
and more lethargic, with lower level of tolerance for hunger, and crave for snacks or 
junk food that provides fast energy. Truthfully, it is not that the person actually lacks the 
essential nutrients; it is that they lack the suffi  cient and efficient flow of open traffic to 
get the materials to their places. 
When the def ciency of qi in the Spleen becomes chronic, and the transportation 
function decreases, this leads the Spleen to fail to move and transform water fluids 
efficiently as well, leading humid to gather and collect and to accumulate into 
symptoms of dampness and to even congeal into phlegm. 
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When phlegm [4,98] is produced, a myriad of other problems arise with it, and at this 
stage, the patient  feels fatigued, experiences lower immunity, frequently develops 
edema and chest oppression, and  develops a lot of sputum in the Lungs. Since the 
patient is lethargic, it leads to less exercise, starting a  vicious cycle of accumulation of 
more phlegm and eventually of fat. Therefore, the basic  treatment  principle for all the 
aforementioned problems is to balance and strengthen the Spleen, which will  
eventually help the body to stop craving food and also effectively get rid of humidity 
and phlegm from the body. 
The analogy between the flow of qi and the flow of traffic will work much better if you 
think of Your body’s energy transportation system as a system of canals. 
With Spleen qi deficiency in the background, there are multiple factors that aggravate 
the situation.One is excessive heat in the Stomach. Too much heat combusts foods too 
fast, produces hunger, andleads the person to develop a propensity to overindulge. A 
person can naturally have a lot of innate heat compared to others, but it can also be 
kindled up by eating a lot of heat-producing foods such as hot, spicy, greasy, and oily 
foods.  
In Traditional Chinese Medicine (TCM), good health consists of the body's systems 
acting in harmony  according to the individual's constitution. If all is working well, there 
will not be any weight problem.  
TCM takes a holistic  approach to obesity by focussing on the underlying changes in the 
body. According  to TCM principles, development of obesity is due to the following 
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pathological changes (Integrated Chinese Medicine Holdings  LTD. [ICMHL], Shen-
Nong Info. a). 
A. DYSPEPSIA CAUSES STOMACH HEAT AND POOR SPLEEN 
FUNCTIONING 
Over consumption of heavy, greasy and spicy foods or alcohol facilitate production of 
heat evils in the stomach.  Meanwhile, inadequate exercise after eating these types of 
foods damages the spleen function.  The over-heated stomach will ripen an excessive 
amount of food.Therefore, the stomach  will digest  food  easier and make an individual 
feel hungry, but the spleen cannot handle an excessive food load  causing it  to under 
function and be  unable to carry out its transformation and transportation functions 
properly.  
As a   result, the spare metabolic products turn into turbid fluid and phlegm which 
intermix with blood and  qi  (vital energy) filling up  the organs, bones and muscles. 
B. EXOGENOUS EVILS GIVING RISE TO OBESITY 
Invasion of exogenous evils or over consumption of greasy foods leads to poor 
transformation and transportation functions of the spleen. Dampness evils then begin to 
accumulate in the middle burner, which is  part of the triple burner (the passage through 
which water, food and fluid are transported).  
When  dampness and  turbid fat enter these passages, they are further distributed by the 
lungs, allowing  penetration into all the organs internally. Additionally, exogenous evils 
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can also penetrate the skin,  subcutaneous tissue and muscles through the body's surface 
giving rise to obesity. 
C.QI (VITAL ENERGY) STAGNATION CAUSES TURBID PHLEGM 
ACCUMULATION 
For those who are emotionally disturbed, experience trauma, have menstruation 
problems or are elderly,  the  liver can fail to regulate qi flow which in turn affects 
digestion and blood flow. The resulting sluggish qi and blood flow tend to block the 
meridians. Therefore, in these people, dampness is likely to endure in  the body.  
Over time, this will congeal into phlegm and result in obesity. 
D. KIDNEY ESSENCE EXHAUSTION LEADS TO DISHARMONY 
Lifestyles, which consume kidney essence, such as being sexually over active can lead 
to the excitation of the internal ministerial fire. The excessive ministerial fire is a kind 
of "evil fire" which makes the body  produce an over abundance of heat. This "evil fire" 
affects the middle burner, leading to a malfunction of  the stomach and spleen. When 
this persists over a long period, the vaporization processes in the bladder  and triple 
burner are impaired causing more evils to accumulate and worsen the  obesity condition. 
From TCM experience, the above causes of obesity can appear together or separately. In 
short, the fundamental causes of obesity are spleen and kidney deficiencies, which 
manifest as an overflow of body  fluids, accumulation of dampness and phlegm evils 
and stagnation in blood flow. Sometimes stomach heat and qi stagnation are associated. 
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Moreover, improper vaporization of body fluids by the triple burner  may also appear. 
All of thesefactors play an important role in the development of obesity. 
TYPES OF OBESITY FROM A TCM PERSPECTIVE 
Syndrome identification is the premise and foundation of TCM treatment. Currently 
there are still no  standardized obesity patterns, ranging from 3 to 12 patterns by clinical 
reports. Most often, simple obesity  was classified into deficiency syndrome and excess 
syndrome by syndrome differentiation of TCM, which further classified into four types 
(ICMHL, Shen-Nong Info.b). 
1. EXCESSIVE INTERNAL PHLEGM AND DAMPNESS DUE TO SPLEEN 
DEFICIENCY 
Phlegm is an important concept in TCM. TCM holds that fat or adipose tissue is mostly 
due to phlegm and  dampness evils. The spleen is regarded to be at the root of all 
phlegm production. When the spleen  becomes damaged, such as eating too many sweet 
foods and getting too little exercise, it will fail in its  duty to move and transform waste 
fluids and foods. Instead these metabolic wastes will  
gather, collect and  transform into evil  dampness. If dampness evils endure, over time 
they will congeal into phlegm, and  become fat tissue.The excessive internal phlegm 
manifests itself as excess weight, accompanied by tiredness, body  
heaviness,  chest  and/or stomach distension, and in some cases poor appetite. The 
tongue has a slimy covering of fur, while  there  is a rolling, taut pulse. This type of 
37 
 
obesity is generally due to an eating disorder, or secondarily by some  other  illness. 
Treatment revolves around sweeping away phlegm and  removing stagnation. Once the 
phlegm is swept away, the qi can move smoothly and easily. This promotes the 
movement of phlegm and  reduction of fat with the ultimate result of decreasing obesity. 
2.STAGNATION OF QI AND BLOOD 
Patients exhibiting this condition may suffer from irritability or low motivation, chestor 
breast fullness, insomnia, a dreamy state, menstrual disorder or amenorrhea (absence of 
menstruation), and infertility.  
Some  patients may complain of headaches. There may be dizziness and numbness of 
the four extremities; and the  tongue is dark red with a white thin fur or a thin and 
greasy fur. The pulse is thready  and rolling. This is because  the movement of blood is 
not smooth or easily flowing. Stasis obstructs  the vessels and inhibits the qi 
mechanism. Therefore, fat and dampness collect and accumulate within  the  vessels, 
making the blood more  viscous. If this continues over time, obesity and arteriosclerosis 
(thickening and hardening of the arteries) will  result. The principle treatment is to speed 
up the blood  flow and remove stagnation. 
3.YANG DEFICIENCY OF SPLEEN AND KIDNEY 
In the case of yang deficiency of spleen and kidney, there is not enough qi to transform 
or melt the phlegm. People in this category often feel exhausted or fatigued. They may 
experience lower back and knee weakness, shortness of breath, impotence or low libido. 
The pulse is deep and fine, the tongue is pale and without any fur covering. Genetic 
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factors can play a part in this condition. It may also be the result of other illnesses, stress 
or an unhealthy lifestyle. 
Treatment involves fortifying the spleen and rectifying the kidney deficiency. 
4.LIVER STAGNATION 
Liver stagnation caused by prolonged strong emotions or depression leads to 
disharmony between the spleen  and the liver and gives rise to fluid retention. Due to 
the liver being depressed, the gall bladder is  also depressed  and exhausted; the ebb and 
flow of these organs become unbalanced, and the qi mechanism does not flow freely.  
Hence fat turbidity is difficult to be transformed and over time it leads to obesity. 
People in this category tend to have excessive fatty material deposited in the abdomen. 
The physique is  bloated  and individuals feel drained of energy. Individuals may also 
experience excess sputum secretion, dizziness, vertigo, retching, a dry mouth, lack of 
desire for food or drink and discomfort in chest and  abdomen. A white glossy or greasy 
coating usually covers their tongues. The pulse is rolling. Treatment involves improving 
liver functioning, unblocking the gallbladder and moving stagnation. 
INDIVIDUALIZED ACUPUNCTURE FOR THE TREATMENT OF OBESITY: 
EFFECTS AND METHODS 
In terms of more healthy and holistic methods of weight loss in Chinese medicine, the 
fundamental prescriptive methodology is to “bian zheng lun zhi”—base treatment on the 
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patient's personal pattern discrimination. TCM doctors diagnose the name of a disease 
followed by the differentiation diagnosis of  syndromes, for prescribing a  treatment.  
Acupuncture treatment based on a patient's syndrome differentiation is both safe and 
effective because it  addresses that person's own metabolic reasons for being overweight 
or obese. Using this method, each  obese  patient can receive his or her own individually 
tailored acupuncture treatment plan.Very basically, acupuncture is the insertion of 
stainless steel filiform needles into precisely specified  acupoints  on the body's surface , 
in order to influence physiological functioning of the body. 
According to TCM, the meridian system provides the transportation channel for the 
fundamental substances of qi,  blood, and body fluids, and along the fourteen main 
meridians there are a total of 365  acupoints have been  identified, each point belongs to 
a particular meridian and connects to a corresponding organ that make it exert particular 
therapeutic properties.TCM holds that obesity is caused by anomaly transportation and 
transformation of the body fluid, accumulation  of water-dampness and phlegm 
turbidity, which are the result of disorders of zang-fu  
organs, stagnation of qi and  blood, disharmony of the Thoroughfare and Conception 
vessels. Therefore  the weight loss can be achieved by  needling meridian points to 
balance yin-yang, regulate zang-fu  organs, promote flow of qi and blood of the  
meridians, and eliminate the inner pathogenic factors by  means of dredging meridian 
and collateral.Accordingly, different set of points would be used, depending on which 
organ(s) needed to be energized  or  inhibited. Furthermore, acupuncture needles can be 
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twirled, electrically stimulated, penetrated to different depths and left in place for 
variable lengths of time. 
A.INDIVIDUALIZED ACUPUOINTS SELECTION 
Acupuncture for weight loss refers to the therapeutic approach applying acupuncture or 
moxibustion on  some  special points under the guidance of meridian theory of the 
TCM. For point selection, the acupoints  zhong-wan, xia-wan, liang-men and tai-yi were 
offen used to regulate stomach qi, remove dampness to  restore normal function of the 
spleen. Acupoints tian-shu and da-heng were selected to promote qi  circulation and 
remove  obstruction in the collaterals. Acupoints qi-haiand guan-yuan were used to  
reinforce the kidney. Acupoints wailing, shui-dao, qu-chi, zhi-gou and nei-ting were 
selected to  eliminate  the dampness and heat,induce diuresis to alleviate edema, and 
promote qi flow to relax the  bowels. 
Besides these routine points (mainly the points of Conception Vessel, Spleen, Stomach, 
Kidney, and Bladder Meridians) which were often selected as chief acupoints in the 
acupuncture treatment of obesity, different adjunct acupoints were added depending on 
the types of disharmony pattern. 
Liu et al. (2004) used the following therapeutic principle and acupoints selection in their 
clinical practice: 
 
 
41 
 
 PATTERN OF EXCESSIVE HEAT IN THE STOMACH AND INTESTINES: 
The treatment was designed to clear away heat from the stomach and intestines. The 
auricular points selected were external nose, small intestine and large intestine, and the 
body acupoints selected were nei-ting, shang-ju-xu, tian-shu, and qu-chi. 
 PATTERN OF LIVER QI STAGNATION: 
The treatment was designed to soothe the liver, regulate qi, activate bIood and disperse 
blood stasis. The auricular points selected were liver, heart, pancreas and gall bladder, 
and the body acupoints selected were gan-shu, ge-shu, tai-chong, and qu-quan 
PATTERN OF DAMP ACCUMULATION BY SPLEEN DEFICIENCY: 
The treatment was designed to clear away heat, remove dampness, dry up dampness and 
strengthen the  spleen. To clear away heat, the auricular points selected were sanjiao, 
spleen and lung, and the body  acupoints selected were  shui-fen, qi-hai, yin-lingquan, 
zu-lin-qi. To dry up  dampness and strengthen the  spleen, the auricular points selected 
were spleen, kidney and san-jiao, and the body  acupoints selected  were pi-shu, zhong-
wan, zu-san-li and tai-bai. 
PATTERN OF DEFICIENCY IN BOTH HEART AND SPLEEN: 
The treatment was designed to reinforce the heart and spleen. The auricular points 
selected were heart, spleen and endocrine, and the body acupoints selected were xinshu, 
pi-shu, nei-guan and zu-san-li. 
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 PATTERN OF DEFICIENCY IN BOTH THE SPLEEN AND KIDNEY: 
The treatment was designed to tonify the kidney,strengthen the spleen and benefit 
qi.The auricular points  selected were spleen, kidney and endocrine, and the body 
acupoints selected were shen-shu, pi-shu, tai-xi  and zu-san-li. 
 PATTERN OF YIN DEFICIENCY IN THE LIVER AND KIDNEY: 
The treatment was designed to nourish the liver and kidney. The auricular points 
selected were liver, kidney and  endocrine, and the body acupoints selected were 
ganshu, shen-shu, guan-yuan and san-yin-jiao. 
PATTERN OF DEFICIENCY IN BOTH LUNG AND SPLEEN: 
The treatment was designed to tonify and benefit the lung and spleen. The auricular 
points selected were lung, spleen and san-jiao, and the body acupoints selected were fei-
shu, pi-shu, zu-san-li and lie-que. 
PATTERN OF QI DEFICIENCY IN THE HEART AND LUNG: 
The treatment was designed to tonify and benefit the heart and lung. The auricular 
points selected were  heart, lung and ear shen-men, and the body acupoints selected 
were xin-shu, pi-shu, fei-shu, nei-guan and  dan-zhong.In case of heart palpitations and 
shortness of breath add shen-men and nei-guan; for scanty urine add shui-fen and yin-
ling-quan; for qi depression, nei-guan and tai-chong need to be added; for yin deficiency 
and heat, tai-xi  and zhao-hai need to be added; for menopausal obesity, qi-hai, guan-
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yuan, pi-shu, shen- shu, tai-xi, or ming-men  need to be added; for complications of 
high blood sugar (e.g.,  
deficiency of both  qi and yin), yang-chi, wan-gu,ran-gu, san-yin-jiao, yi-shu and shen-
shu need to be added; for  excessive  appetite (e.g., excessive heat of spleen and 
stomach), liang-men, liang-qiu, nei-ting, gong-sun, fei-shu  and  wei-shu need to be 
added. 
MECHANISMS AND METHODS OF ACUPUNCTURE 
Acupuncture, practiced for several thousand years in China, [100] is increasingly used 
worldwide in the treatment of many disorders. An accumulating body of evidence 
summarized in a NIH Consensus Statement on Acupuncture [101] confirms that 
acupuncture treatment has beneficial effects for conditions  ranging from postoperative 
dental pain to chemotherapy-associated emesis. It is also effective as an  adjunctive 
modality for joint and muscle pain, addictions,and asthma. 
MERIDIANS AND ACUPOINTS 
In Traditional Chinese Medicine (TCM), life force or ‘Qi’ (‘chee’) is thought to 
circulate within energy  pathways or ‘meridians’ longitudinally throughout the body. 
There are 14 major meridians, corresponding  (loosely) to the Western definition of 
‘organs.’ Acupuncture points are specific locations on the body  considered to be 
connected to these energy meridians.[101–103] During  illness Qi is thought to be  out of 
balance, and stimulation of acupuncture points corrects this imbalance. Theoretically, an 
‘excess’  or ‘deficiency’ of Qi can be ‘normalized’ by the specific manner of point 
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stimulation. Using this  paradigm, obesity and/or  xcess appetite has been 
conceptualized in a variety of ways, such as ‘heat’  in  the stomach and intestine,[28,104] a 
deficiency of Qi in the spleen and stomach [28,29 ,104,105]or a deficiency of primary Qi [ 104]. 
Based on these beliefs about the causes of  obesity, a variety of acupoints are targeted in 
the treatment of obesity,  
including: Neiguan (P 6), Fenglong (St 40), Liangmen (St 21), Guanyuan (R 4), Zusanli 
(St 36), Tianshu (St 25), Quchi (LI  11), where P refers to a pericaridium point ,Lu 
refers to lung point, St to stomach, K to kidney, and LI to large intestine.[106]. 
In terms of traditional medicine, it is believed that acupuncture works to alter central 
nervous system neurotransmitter levels by stimulating peripheral nerves at acupoints. 
These stimulated nerves then carry the signals centrally,[31,32,107,108] shown in Figure 1, 
including to the spinal cord, pituitary, and  midbrain. Activated centers can then release 
neurochemicals: endorphins, monoamines, and cortisol  [107]. 
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ACUPOINT STIMULATION 
A large number of acupuncture points (365 points have been identified in Chinese 
acupuncture maps) show concentration of peripheral nerve junctions, referred to as 
‘trigger points’[102].A variety of methods  are used to stimulate acupoints.[101, 107, 109]. 
These include:1. Needling or ‘traditional acupuncture’, in which fine stainless-steel 
needles are inserted through the skin  
 
 
FIGURE-6 SIMPLIFIED THEORETICAL PATHWAY OF NEEDLE 
STIMULATION SENDING NERVE IMPULSES TO BRAIN AND INTERNA 
MERIDIAN PHENOMENA WITH HOLISTIC THEORY 
According to classic acupuncture theory, there are two opposing and complementary 
forces that coexist in  nature: Yin and Yang. These two forces interact to regulate the 
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flow of Qi (pronounced chee). The traditional concept is  usually regarded as energy or 
life force. When a person is in “good health,” that means Yin and  Yang are in  balance 
and then the flow of Qi is smooth. When Yin and Yang become  “unbalanced,” there  are 
disturbances in  Qi, which lead to illness and disease [110]. The Qi circulates through all 
parts of the  body via pathways called meridians, which bring Qi from the internal 
organs  to the skin surface. Up to 365 points along and around these meridians which 
could be stimulated to correct the imbalance and restore the body to normal health are 
called acupoints [111]. 
Although the physical evidence for the existence of meridians has not been identified 
after years of investigation, some meridian phenomena can be found, especially with 
modern technologies [112]. A number of researchers hold the view that when some 
internal organs are affected by disease, acupoint sensitization has the potential for 
exerting dynamic functional changes, reflecting acupoint specificity [113]. 
Cheng et al. made a model of acute gastric mucosal injury (AGMI) in rats and observed 
the plasma extravasated Evans blue (EB) points on the skin of the whole body.They 
found that four acupoints interacting with stomach appeared extravasated EB points. 
Furthermore, the number of extravasated EB points was related to the phase of gastric 
mucosal injury, being greatest on the 2nd and 3rd days after  modeling and disappearing 
gradually along with the natural repair of the AGMI [114]. Some research findings 
suggested that the anatomical structure of meridian channels and acupoints was related 
to the connective tissues and the connective tissue interstitial fluid (CTIF) system [115 -122 
].  
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In particular, Yuan et al. analyzed the digital images from slices of   cadavers and found 
that 365 acupoints were located in five types of connective tissues [123]. Dang et al.  
Indicated that 9 out of 11 acupoints of the  lung meridian were on the periosteum [117] . 
Furthermore, another crowd of people devoted to examine the relationship between 
perivascular space (PVS) and the meridian. According to the perivascular dye injection 
and frozen section histology, they found that there was PVS around the blood 
vesselsalong the meridians, and it is a fluid pathway.  Subsequent physiologic studies  
revealed that the PVS has significantly greater electrical conductivity and  significantly 
higher partial oxygen  pressure (pO2) compared to medial and lateral tissues [124]. 
EFFECT OF ACUPUNCTURE ON NEURO–ENDOCRINE–IMMUNE 
NETWORK SYSTEM 
EFFECT OF ACUPUNCTURE ON NERVOUS SYSTEM 
The direct feeling during acupuncture is de qi, an internal composite sensation of 
soreness, numbness,heaviness, distension and aching, and a radiating sensation at and 
around the acupoints. The sensationof de qi is most closely related to nervous system. 
Therefore, most of these studies focus on nervous system.  Many studies have found 
that acupuncture can directly or indirectly activate the nervous  
system, causing  changes of functional activities in different levels of the nervous 
system, and then playing imodulatory role  through release of related neurochemicals. 
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EFFECT OF ACUPUNCTURE ON NEURAL ACTIVITIES 
The main form of nervous system functional activities is electrical activities. 
Electrophysiological studies  of  neural activities show that acupuncture stimulation can 
cause peripheral afferent nervfibers to be  excited . [125].  
On one hand, the excitement could be transmitted via spinal cord [126] to brain [127] and 
after central  integration, efferent nerves  transfer information to the target organs. On 
the other hand, the excitement  could be transmitted through axon reflex to target organs  
[128]. eventually showing regulatory effect. Thus, acupuncture can cause discharge 
activities of different parts in nervous system, regulating nerve  
functions at different levels. In recent years, many studies of acupuncture effect on 
neural  functional  activities have introduced advanced noninvasive neuroimaging 
technologies, includingpositron  emission tomography, single proton emission 
computerized tomography and functional magnetic resonance imaging. 
These powerful imaging technologies make it possible to visualize the anatomic and 
functional effectsof acupuncture stimulation in the brain. Studies have shown that 
acupuncture can cause changes of activities in  different functional areas of human or 
animal brain [129]. It provides evidence that acupuncture can affect neurons functional 
activities in the brain 
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EFFECT OF ACUPUNCTURE ON NEUROCHEMICALS 
Researches carried out in the past years have shown that acupuncture can affect 
synthesis, release and action of several neurotransmitters (such as serotonin, dopamine, 
catecholamine, glutamate, acetylcholine, etc.) and neuropeptides (such as oxytocin, 
neuropeptide Y, cholecystokinin, vasoactine intestinal peptide, substance P, calcitonin-
gene-related peptide, pituitary adenylate cyclase activatingpolypeptide, etc.) in both the 
central and peripheral nervous systems [130,131].The changes  of  neurotransmitters and 
neuropeptides  caused by acupuncture are different due to different diseases orneedling 
parameters. 
EFFECT OF ACUPUNCTURE ON ENDOCRINE SYSTEM 
Because of the hypothalamus–pituitary–adrenal (HPA) axis, hypothalamus–pituitary–
gonadal (HPG)axis and hypothalamus–pituitary–thyroid (HPT) axis playing an 
important role in the endocrine activities, recent researches about the effects of 
acupuncture on the endocrine system more focused on these axes, with related 
hormones as observation indexes. For example, acupuncture could obviously 
reduce hormones such as adreno corticotropic hormone (ACTH), corticosterone related 
to HPA axis in chronic stress-induced rats [132]. Electroacupuncture (EA) could regulate 
the level of uterus estrogen,  pituitary follicule-stimulating hormone and luteinizing 
hormone and hypothalamic gonadotropin releasing hormone in ovariectomized rats, to 
restore the disorder of hypothalamus–pituitary–ovary axis [133]. 
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Acupuncture could increase the level of thyrotropin releasing hormone, thyroid 
stimulating hormoneand total three typical thyroid original acid in chronic fatigue rats, 
to restore the inhibition of HPT axis [134]. All these studies suggest that acupuncture can 
modulate the function of HPA, HPG and HPT axes. 
EFFECT OF ACUPUNCTURE ON IMMUNE SYSTEM 
Effect of acupuncture on local immunomodulation of acupoint 
Modern studies have found that after inserting the needle into the acupoint, traumatic 
inflammationoccurs in the acupoint, activating the local immunomodulation at the 
acupoint [135].Our studies also showed that acupuncture could initiate mast cells to 
gather in the acupoint, secreting bioactive  substances such as histamine, bradikinin, SP 
and serotonin. These secretions caused vasodilatation, increased local  permeability and 
local reaction. At the same time, inflammatory cell infiltrated, cytokines (IL-1b, IL-6,  
IL-8,  TNF-a  and IL-4) and adhesion molecules (E-selectin and L-selectin) increased in 
the acupoint. These changes led a local inflammation in acupoints [136]. 
EFFECT OF ACUPUNCTURE ON NONSPECIFIC IMMUNITY 
Numerous researches have shown that acupuncture can regulate the nonspecific immune 
function [137]. including the following aspects: acupuncture can improve the number and 
function of phagocytes, increase the number and activity of natural killer (NK) 
cell,promote the synthesis, secretion and  biological activities of cytokines and adjust 
the content of serum complement. 
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EFFECT OF ACUPUNCTURE ON SPECIFIC IMMUNITY 
Studies have shown that acupuncture has certain regulating effect on both cellular 
immunity and humoral immunity [138,139]. The influence of acupuncture on cellular 
immunity mainly include that it can  promote the proliferation of T cells, improve the 
ratio of CD4+ T cells/CD8+ T cells and modulate the  synthesis and secretion of 
cytokines in the immune response. The effect of acupuncture on humoral  immunity 
mainly includes the following aspects: it can modulate the synthesis and secretion of 
various kinds of immunoglobulin and promote T-helper lymphocytes secreting 
cytokines. 
EFFECT OF ACUPUNCTURE ON NEURO–ENDOCRINE–IMMUNE 
NETWORK 
With the development of researches, scholars have found that acupuncture has 
modulating effect onthe nervous, endocrine and immune systems. A researcher 
proposed a hypothesis, that was ‘thebidirectional positive regulatory role of acupuncture 
was achieved by neuro-endocrine-immune network’ [140]. Subsequently, several 
researches about acupuncture effect on NEI network were carried out, with related 
indicators of the three systems such as neurotransmitters, endocrine hormones, immune  
cells  or cytokines as observed indexes. Ju et al [141]. conducted the related research at 
the early time. It’s  about acupuncture analgesia, finding that there was a NEI regulatory 
loop in the acupuncture analgesia.  
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In  addition,  human studies have also indicated that acupuncture can modulate the NEI 
network. Liu and co- workers[142]found  that acupuncture can regulate the concentration 
of plasma IL-2, prostaglandin E2, mbright  enkephalin and NK cell  activity in patients 
with rheumatoid arthritis. These suggested that  acupuncture could  modulate the  NEI  
network. 
Further studies showed that acupuncture could also modulate some common signaling 
molecules of  NEI network. For example, EA could promote T-cell immune responses 
in aging rats, with several common signaling molecules of NEI network involved in, 
such as serum IL-6, hippocampus IL-6R, hypothalamus  b-endorphin and corticotropin- 
releasing hormone, ACTH and corticosterone of HPA axis[143] But it  remains to be 
studied that how  acupuncture modulate the common signaling molecules. 
ACUPUNCTURE POINTS 
ZHIGOU : BRANCH DITCH   
SJ-6 : HAND SHAOYANG TRIPLE BURNER 6  TW 6 
 
 SJ-6 : HAND SHAOYANG TRIPLE BURNER 6  TW 6 
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CLASSIFICATIONS: 
Jing-River and Fire point 
Horary point of the Sanjiao channel 
LOCATION: 
3 cun proximal to Yangchi SJ-4, in the depression between the radius and the  ulna, on 
the radial side of the extensor digitorum communis muscle.  
NEUROANATOMY: 
Superficial Innervation: Posterior cutaneous nerve of the forearm from C5 - C8 
Dermatome Segment: C6, C7 
Needling: 
Slightly oblique insertion towards the ulnar side or oblique proximal or distal insertion 
towards the elbow or wrist respectively 0.5 - 1.5 cun, or joined by through needling to 
Jianshi P-5. 
Warning: 
Movement of the patient's hand or arm after needling this point can result in a bent 
needle. 
TCM ACTIONS: 
 Regulates qi and clears heat in the three jiao  
 Benefits the chest and lateral costal region  
 Moves the stool  
 Benefits the voice  
 Activates the channel and alleviates pain 
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TCM INDICATIONS: 
 Tinnitus, heat-wind tinnitus and deafness, sudden loss of voice, lockjaw, febrile 
disease with absence of sweating, pain of the eyes, redness, swelling and pain of 
the eyes, swelling and pain of the throat, scrofula.  
 Pain of the lateral costal region, abdominal pain, sudden Heart pain and 
oppression of the chest, cough, cough with redness and heat of the face.  
 Constipation, vomiting, sudden turmoil disorder, post-partum dizziness, blockage 
of the Ren Mai in women.  
 Pain of the axilla, pain of the shoulder, arm and back, painful obstruction of the 
elbow, tremor of the hand, cold-wind hand trembling, numbness of the hand, 
hemiplegia. 
ZHANGMEN:COMPLETION GATE LIV-13  FOOT JUEYIN LIVER 13  
 
\ 
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CLASSIFICATIONS: 
Front Mu point of the spleen  
Hui-Meeting point of the zang  
Meeting point of the liver and gall bladder channels  
Origin of the Dai Mai 
Meetings: 
Meeting of Liver with Dai Mai, Gall Bladder Divergent and Liver Divergent 
LOCATION: 
Directly anterior and inferior to the free end of the eleventh rib. This point is usually lies 
just above the level of the umbilicus and on or near the mid-axillary line.  
 NEUROANATOMY: 
Superficial Innervation:  
 Lateral cutaneous thoracic nerve from T11 
Dermatome Segment: T11 
Needling: 
Transverse of oblique insertion medially or laterally, along the line of the rib 0.5 - 1 cun 
Warning: 
Deep perpendicular needling may damage an enlarged liver or spleen 
TCM ACTIONS: 
 Harmonises the liver and spleen  
 Regulates the middle and lower jiao  
 Fortifies the spleen  
 Spreads the liver and regulates qi 
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TCM INDICATIONS: 
 Injury to the Stomach and Spleen from overindulgence in eating, focal 
distension, distension and pain of the abdomen, drum distension, abdominal (ju 
ji) masses, oesophageal constriction, vomiting, pain of the Heart with vomiting, 
no pleasure in eating, undigested food in the stool, borborygmus, diarrhoea, 
constipation, emaciation and jaundice, frequent urination with turbid white 
discharge.  
 Fullness of the chest and lateral costal region, pain of the ribs, sudden difficulty 
in breathing, inability to catch the breath, dyspnoea, cough, stone oedema.  
 Weariness of the four limbs, running piglet qi with distension of the abdomen, 
diminished qi with inversion counterflow.  
 Agitation and heat with dry mouth, propensity to anger, propensity to fear, mad 
walking, epilepsy.  
 Cold and pain of the lumbar spine, rigidity of the spine, lumbar pain with 
inability to turn and bend the waist, inability to raise the arm and shoulder. 
SHOUSANLI : ARM THREE MILES   
LI-10 : HAND YANGMING LARGE INTESTINE 10 
 
 
57 
 
CLASSIFICATIONS: 
Homeostatic point 1 (Ma, Ma & Cho, 2005, Biomedical Acupuncture for Pain 
Management)  
Trigger point (Travell & Simons, 1998, Trigger Point Manual) 
LOCATION: 
On the radial side of the forearm, 2 cun distal to Quchi L.I.-11 on the line connecting 
Quchi L.I.-11 with Yangxi L.I.-5  
Neuroanatomy: 
Superficial Innervation: Posterior cutaneous nerve of the forearm (C6 - C8) 
Dermatome Segment: C5 
Deeper Structures: Deep radial from the posterior branch of the brachial plexus (C5 - 
T1) 
Needling: 
Perpendicular or oblique insertion, 0.5 - 1.5 cun 
TCM ACTIONS: 
 Regulates qi and blood,  
 activates the channel  
 alleviates pain  
 Harmonises the intestines and stomach 
TCM INDICATIONS: 
 Abdominal pain, vomiting and diarrhoea, periodic sensation of cold in the 
intestines,  
 sudden turmoil disorder.  
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 Toothache with swelling of the cheek, deviation of the mouth, loss of voice, 
scrofula. 
 
ZUSANLI : LEG THREE MILES  
ST-36 : FOOT YANGMING STOMACH 36 
 
 
CLASSIFICATIONS: 
He-Sea and Earth point 
Gao Wu Command point  
Ma Dan-yang Heavenly Star point  
Point of the Sea of Water and Grain  
Horary point of the Stomach channel  
Trigger point (Travell & Simons, 1998, Trigger Point Manual; Melzack, Stillwell & 
Fox, 1977,  
Trigger  Points and  Homeostatic point 24 (Ma, Ma & Cho, 2005, Biomedical 
Acupuncture for Pain Management) 
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LOCATION: 
Below the knee, 3 cun inferior to Dubi St-35, one fingerbreadth lateral to the anterior 
crest of the  tibia.  
NEUROANATOMY: 
SUPERFICIAL INNERVATION: Lateral femoral cutaneous nerve of the calf (L4 - 
S1) 
Dermatome Segment: L5 
Deeper Structures: Common fibular (peroneal) nerve (L4 - S3) 
Needling: 
Perpendicular insertion 1 - 1.5 cun 
TCM ACTIONS: 
 Activates the channel and alleviates pain  
 Fortifies the spleen and resolves dampness  
 Supports the correct qi and fosters the original qi  
 Tonifies qi and nourishes blood and yin  
 Clears fire and calms the spirit  
 Activates the channel and alleviates pain  
 Revives the yang and restores consciousness 
TCM INDICATIONS: 
 Epigastric pain, nausea, vomiting, bitter vomiting, vomiting pus and blood, 
hiccup, belching, distension and pain of the abdomen, fullness and distension of 
the Heart and abdomen, heat in the middle jiao with propensity to hunger, hunger 
without desire to eat, poor appetite, difficult ingestion.  
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Borborygmus, flatulence, diarrhoea and dysenteric disorder, undigested food in 
the stool, cold in the middle jiao with borborygmus, cold in the intestines, 
chronic diarrhoea, sudden turmoil  disorder, leg qi, oedema, heaviness of the four 
limbs, lower abdominal pain and swelling with  inability to urinate, jaundice.  
The five taxations and the seven injuries, insufficiency of original qi, 
insufficiency of yin qi, insufficiency of zang qi, insufficiency of Stomach qi, 
deficient dyspnoea, shortness of breath and cough, dyspnoea with inability to 
stand for long.  
Dizziness, post-partum blood dizziness, dimness of vision, tinnitus, palpitations, 
hypertension.  
Mania-depression, manic singing, raving, abusive talk, anger and fright, tendency 
to sadness, outrageous laughter, agitation with heat in the body.  
 Throat painful obstruction with inability to speak, chills and fever, febrile disease 
with absence of  sweating, febrile disease with heavy head and pain of the 
forehead, headache, cold nose, pain of the brain, pain of the lateral costal region, 
blood stasis in the interior, blood stasis in the chest, sudden Heart pain, fullness 
of the chest and lateral costal region, qi rushing up to the chest.  
 Lock jaw, clonic spasm, loss of consciousness.  
 Breast abscess, swelling of the breast, pain of the knee and shin, pain of the thigh 
and shin,  wind stroke, hemiplegia, muscle pain, chronic painful obstruction, 
lumbar pain with inability to turn, shan disorder. 
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TIANSHU :HEAVEN'S PIVOT  
ST-25 : FOOT YANGMING STOMACH 25 
 
CLASSIFICATIONS: 
Front Mu of the Large Intestine  
Meetings: 
Meeting of Stomach with Kidney Divergent and Large Intestine Divergent 
LOCATION: 
On the abdomen, 2 cun lateral to the umbilicus.  
NEUROANATOMY: 
Superficial Innervation: Cutaneous branches of thoracic nerves from T10 
Dermatome Segment: T10 
Needling: 
Perpendicular insertion 1 - 1.5 cun Oblique inferior insertion towards the uterus for 
diseases of the  uterus 
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Warning: 
In thin subjects, deep needling may penetrate the peritoneal cavity 
TCM ACTIONS: 
 Regulates the intestines  
 Regulates the spleen and stomach  
 Resolves dampness and damp-heat  
 Regulates qi and blood and eliminates stagnation 
TCM INDICATIONS: 
 Diarrhoea, Spleen-diarrhoea, persistent, diarrhoea with undigested food in the 
stool,  
 dystenteric disorder, borborygmus, lower yuan (origin) deficient and cold, 
constipation. Oedema, drum distension, swelling of the face, turbid painful 
urinary dysfunction.  
 Vomiting, retching, difficult ingestion, poor appetite, sudden turmoil disorder.  
 Abdominal pain, abdominal distension with laboured breathing, intestinal 
abscess,  
 generalised, swelling with severe cutting periumbilical pain, umbilical shan 
disorder with localised pain that periodically surges up the Heart, shan disorder, 
running piglet qi.  
 Abdominal (zheng jia) masses in women, pain of the uterus, dysmenorrhoea, 
irregular  
 menstruation, infertility, red and white leucorrhoea.  
 Cold shivering from malaria, severe heat with manic raving 
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QIHAI : SEA OF QI  
REN-6 : EXTRAORDINARY CONCEPTION VESSEL 6 
 
 
LOCATION: 
On the midline of the lower abdomen, 1.5 cun inferior to the umbilicus and 3.5 cun 
superior to the pubic symphysis. 
NEUROANATOMY: 
Superficial Innervation: Anterior cutaneous thoracic nerves from T11 or T12 
Dermatome Segment: T11, T12 
Needling: 
Perpendicular insertion 0.8 - 1.5 cun 
Warning: 
Deep needling may penetrate the peritoneal cavity. No deep needling in pregnancy, or 
perpendicular needling in advanced pregnancy. 
TCM ACTIONS: 
 Fosters original qi  
 Tonifies qi  
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 Tonifies the kidneys and fortifies yang  
 Rescues collapse of yang  
 Regulates qi and harmonises blood 
 
TCM INDICATIONS: 
 Zang deficiency with qi exhaustion, original qi deficiency, collapse of yang, slow 
and minute  pulse, yin deficiency with sudden collapse of yang, loss of 
consciousness from windstroke, all kinds of chronic qi disease that do not 
respond to treatment, emaciation of the muscles of the body, feebleness and 
weakness of the muscles, failure of the fontanelle to close in babies, upward 
attack of the qi of the five zang.  
 Impotence, seminal emission, prolapse of the uterus, prolapse of the rectum.  
Deficiency and cold of the lower jiao, inversion counterflow of the four limbs, 
cold illness with dark face, diarrhoea, dysenteric disorder, white and turbid urine, 
dark urine, hesitant urination, childhood enuresis.  
 Uterine bleeding, persistent flow of lochia, post-partum bleeding, irregular 
menstruation, dysmenorrhoea, red and white leucorrhoea, infertility.  
 The seven kinds of shan disorder, twisting pain of the umbilicus, abdominal 
(zheng jia) masses, abdominal distension, pain and cold sensation below the 
umbilicus, retraction of the testicles. Upward staring eyes, constipation, sudden 
pain of the Heart, dyspnoea, lumbar sprain 
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ZHONGWAN : MIDDLE CAVITY  
REN-12 : EXTRAORDINARY CONCEPTION VESSEL 12 
 
 
CLASSIFICATIONS: 
Front Mu point of the stomach  
Hui-Meeting point of the Fu Confluent point of the San Jiao and Pericardium Divergent 
channels (Cecil-Sterman, 2012, Advanced Acupuncture) 
Meetings: 
Meeting of Conception Vessel with Small Intestine, San Jiao, Stomach, Stomach 
Divergent, Spleen  
Divergent, San Jiao Divergent and Pericardium Divergent 
LOCATION: 
On the midline of the abdomen, 4 cun above the umbilicus and midway between the 
umbilicus and  the sternocostal angle. 
NEUROANATOMY: 
Superficial Innervation: Anterior cutaneous thoracic nerve from T8 
66 
 
Dermatome Segment: T8 
Needling: 
Perpendicular insertion 0.8 - 1.5 cun 
Warning: 
In thin patients deep needling may penetrate the peritoneal cavity. No perpendicular 
needling in advanced pregnancy. 
TCM ACTIONS: 
 Harmonises the middle jiao and descends rebellion  
 Tonifies the stomach and fortifies the spleen  
 Regulates qi and alleviates pain 
 
TCM INDICATION: 
 All diseases of the Stomach and Spleen, interior injury to the Stomach and 
Spleen, epigastric, epigastric pain and fullness, difficult ingestion, eats little but 
is easily full, nausea, Stomach reflux, vomiting, vomiting blood, abdominal 
distension, seere pain of the abdomen, sudden abdominal fullness, focal 
distension and fullness, pain of the Spleen, hardness and pain of the lateral costal 
reason.  
Injury by worry, anxiety and overthinking, injury by the seven emotions leading 
to epigastric pain.  
 Diarrhoea, undigested food in the stool, red and white dysenteric disorder, 
difficulty in  
 defecation, heat in the Small Intestine, dark urine, sudden turmoil disorder. 
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 Deficiency-taxation, sallow complexion, post-partum blood dizziness.  
Heart pain, chronic and acute childhood fright wind, loss of consciousness, 
mania-depression, epilepsy, tongue thrusting. Cold body, scorched foul odour in 
the nose, running  piglet qi, dyspnoea. 
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MATERIALS AND METHODS  
Study design : Experimental pre post study  
Study population :  
The present study was conducted in Government Yoga and Naturopathy Medical 
College Hospital, Arumbakkam, Chennai – 600 106. The subjects were thirty outpatient 
from Government Yoga and Naturopathy Medical College Hospital, Arumbakkam, 
Chennai – 600 106.  
Ethical committee clearance: Clearance from the Institutional ethical committee was 
obtained prior to the conduct of the study.  
Written Informed consent  
Subjects who fulfilled inclusion criteria were appraised about the purpose of the study 
and rights as research subjects. Informed consent form was administered in English. 
Adequate time was given to each patient to go through the information sheet and their 
queries were answered. Their right to withdraw from the study and the need for 
willingness to participate voluntarily in the study was explained. All the subjects 
expressed their willingness to participate in the study by giving a signed informed 
consent. (A sample information sheet and consent form is enclosed in Annexure)  
Selection of the subjects:  
Inclusion Criteria:  
 Age :18-35yrs  
 Obesity grade 1 (30.0-34.9kg/m2)  
 Patients conforming to the differentiation of obesity with spleen deficiency  
 Both sexes  
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 Patients who had taken no weight loss drugs in past six months  
 Got informed consent  
 
Exclusion Criteria:  
 Pregnancy  
 Lactating Mothers  
 Participation in other therapies for pain  
 Patient who had taken weight loss drugs in the past six months  
 Patients with secondary obesity caused by severe primary diseases in the brain 
and endocrine system.  
 In any diet restriction for obesity  
 
Data collection and Analysis:  
 Subjects were given a set of spleen qi deficiency questionnaires for scoring. (one 
question- 1 score)  
1. Edema : yes / no  
2. Lassitude : yes / no  
3. Heavy sensation in the body : yes / no  
4. Oliguria : yes / no  
5. Anorexia : yes / no  
6. Abdominal fullness : yes / no  
 Subject whose score was 2 and above were taken into study by measuring their 
height, weight, waist circumference along BMI & waist hip ratio.  
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Assessments of Parameters:  
 WEIGHT  
 BMI  
 WAIST CIRCUMFERENCE  
 WAIST HIP RATIO.  
 
Weight:  
Participants will be weighed in kilograms using a digital weight scale. At the end of the 
examination will display the weight in kilograms.  
BMI:  
Weight in kilograms  
Height in meters2  
Standing Height  
Standing height is an assessment of maximum vertical size.. Standing height is 
measured with a fixed vertical backboard and an adjustable head piece.  
1. Position the subject:  
Direct the subject to the platform. Ask him or her to remove any hair ornaments, 
jewellery, buns, or braids from the top of the head. Exhibit the correct position for the 
measurement of standing height. First, have the subject stand up straight against the 
backboard with the body weight evenly distributed and both  
feet flat on the platform. Instruct the subject to stand with the heels together and toes 
apart. The toes should point slightly outward at approximately a 60ºangle. Check that 
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the back of the head, shoulder blades, buttocks, and heels make contact with the 
backboard.  
Waist circumference  
1. Remove clothing from the waist line.  
2. Stand with feet shoulder width apart (25 to 30 centimetres or 10 to 12 inches) and 
back straight.  
3. Locate the top of the hip bone. This is the part of the hip bone at the side of the waist 
not at the front of the body. Use the area between the thumb and index finger to feel for 
the hip bone at the side of the waist.  
4. Align the bottom edge of the measuring tape with the top of the hip bone. Wrap the 
tape measure all the way around the waist. Ensure that the tape measure is parallel to the 
floor and not twisted.  
5. Take two normal breaths and on the exhale of the second breath tighten the tape 
measure so it is snug but not digging into the skin.  
Hip circumference:  
1. At a level parallel to the floor, at the largest circumference of the buttocks.  
2. Make both measurements with a stretch‐resistant tape that is wrapped snugly around 
the subject, but not to the point that the tape is constricting. Keep the tape level and 
parallel to the floor at the point of measurement.  
Subjects will be Screened (n=30)  
Pre-Assessment scoring questionaries for spleen qi deficiency with score 2 and above 
.anthropometric measurements Such as weight, BMI,waist circumference, waist -hip 
ratio.  
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After screening the subjects will be given a set classical acupuncture points for three 
days in a week for 3 months.  
Post Assessment-anthropometric measurements such as weight, BMI,waist 
circumference, waist -hip ratio, scoring questionaries for spleen qi deficiency to assess 
the changes took place in the subjects.  
Statistical Analysis & Results  
TRAIL PROFILE:  
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INTERVENTION:  
CLASSICAL ACUPUNCTURE POINTS:  
CV-6, CV-12, ST-25, ST-36,LIV-13,LI-10,TW-6.  
NEEDLING  
Needling methods:  
 Subjects were treated with ‘use and throw’ stainless steel needles.  
  Needles with the measurement of 0.25 * 0.25 were used throughout the study.  
  During every visit patients were treated with new needles.  
  Sterile measures were adopted and used needles were carefully disposed.  
  Needles were inserted till the level of the dermis.  
 
After screening the subjects will be given a set classical acupuncture points for three 
days in a week for 3 months.  
After the period of three months same assessment will be done to assess the 
effectiveness of the intervention.  
5) RESULTS:  
Statistical Analysis Plan: Statistical Anal sis done b aired T TEST method  
Statistical Analysis Plan:  
Data was expressed as Mean and SD. Inter group comparison was done using paired t-
test by R statistical free software version 3.2.0.  
` 
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Data Analysis 
 
Data expressed Mean ±SD. Comparison of Mean in between the pre and post 
intervention was analyzed by paired t test. R statistical software version 3.1.1 was used 
for the analysis. P<0.05 set as significant 
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RESULTS 
 
Table: 3 Demographical variable of the study participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables Study group 
Age (yrs) 27.90±3.88 
Height (cm) 153.42±7.52 
Weight (kg) 68.77±9.23 
BMI (kg/m2) 26.23±3.78 
76 
 
 
 
 
 
 
Table 4: Comparison of variables of study group before and after the   intervention 
 
 
 
 
 
 
 
 
 
 
 
Result shows that the intervention efficiently influenced the nervous system by exerting 
a positive influence by creating a dominance of parasympathetic system over 
sympathetic aiding inphysiological and psychological changes resulting in weight 
reduction and also in reduction of BMI,waist hip ratio,waist circumference. 
 
 
 
Variables Study group P value 
Before After 
Weight 68.90±5.70 61.83±6.60 0.05 
BMI 31.50±2.66 28.56±4.20 0.02 
HC 98.24±7.86 96.29±5.50 0.04 
WC 85.60±3.34 81.06±2.90 0.04 
WHR 0.86±0.23 0.83±0.12 0.12 
Total Score 12.60±2.56 3.40±5.28 0.01 
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Table 5: Comparison of WEIGHT of study group before and after the intervention 
 
 
 
 
Result shows that the intervention efficiently reduced weight significantly 0.05 from 
68.90±5.70 to 61.83±6.60. 
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Table 6: Comparison of BMI of study group before and after the  intervention 
 
 
 
 
Result shows that the intervention efficiently reduced BMI significantly 0.02 from 
31.50±2.66 to 28.56±4.20 
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Table 7: Comparison of HC of study group before and after the intervention 
 
 
 
 
 
Result shows that the intervention efficiently reduced HC significantly 0.04 from 
98.24±7.86  to 96.29±5.50 
 
80 
 
 
 
 
 
 
 
 
Table 8: Comparison of WC of study group before  
and after the  intervention 
 
 
 
Result shows that the intervention efficiently reducedWC significantly 0.04 from 
85.60±3.34 to 81.06±2.90 
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Table 9: Comparison of WHR of study group before   
and   after the   intervention 
 
 
 
 
Result shows that the intervention efficiently reduced WHR significantly 0.12 from  
0.86±0.23  to 0.83±0.12 
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Table 10: Comparison of TOTAL SCORE of study group before 
 and   after the   intervention 
 
Result shows that the intervention efficiently reduced WHR significantly 0.01 from 
12.60±2.56    to 3.40±5.28 
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DISCUSSION 
 
 This Experimental pre post study was designed to analyze differences in the 
anthropometric measurements of obese indviduals through acupuncture on specific 
points.  
In this study, we investigated the effect of acupuncture on anthropometric measurement 
of obese individuals showed significant reduction in weight from 68.90±5.70 to 
61.83±6.60 and BMI significantly from 31.50±2.66 to 28.56± 4.20 , HC significantly 
from 98.24±7.86 to 96.29±5.50,WC significantly 0.04 from 85.60±3.34 to 81.06±2.90 , 
WHR significantly 0.12 from 0.86±0.23 to 0.83±0.12 , WHR  significantly 0.01 from 
12.60±2.56 to 3.40±5.28 suggesting that there would be a possible improvement in 
spleen function which aids in proper distribution of energy to various parts of the body 
for optimal physiological functioning.  
You and Hung, 2005 showed that 100 Hz EA (bilateral Zusanli (ST36) and Sanyinjiao 
(SP6) for 30 min during 14 days) significantly in human, a similar reduction in body 
weight, lipid profile (triglycerides, total cholesterol and LDL), as well as in waist and 
hip circumference, was observed when patients were treated with EA for six weeks 
(bilateral Tianshu (ST25), bilateral Weidao (GB28), Zhongwan (CV12), Shuifen (CV9), 
Guanyuan (CV4), Sanyinjiao (SP6), as well as Quchi (LI11) and Fenlong (ST40) for 
obese patients with higher energy, or Qihai (CV6) and Yinlingquan (SP9) for patients 
with lower energy, using 30-40 Hz and dense-disperse wave), followed by a six weeks 
period without any treatment for six weeks and another six weeks period with a low-
calorie diet. These results demonstrated that EA exhibits long-term effects on body 
homeostasis in obese patients [144].  
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Body weight and serum leptin reduction (p<0.000) in response to EA (ear points Sanjiao 
(Hungry) and Shenmen (Stomach), and body points Hegu (LI4), Quchi (LI11), Tianshu 
(ST25), Zusanli (ST36), Neiting (ST44), Taichong (LV3) and Qihai (CV6), once daily, 
for 30 minutes, during 20 days) were also associated with an increase in serum beta 
endorphin (BE) levels (p<0.05). Authors hypothesized that the effect of EA in 
modulating serum BE level could enhance lipolytic activity, which may induce weight 
loss by mobilizing energy stores [145].  
A randomized, sham-controlled preliminary trial confirmed that the significant 
reduction of body weight and body mass index (BMI) in obese women treated with EA 
(Hegu (LI4), Shenmen (HT7), Zusanli (ST36), Neiting (ST44), and Sanyinjiao (SP6) 
bilaterally, two sessions of 20 minutes/week for five weeks) was related to decreased 
levels of leptin. They also observed reduced insulin levels, and increased levels of 
ghrelin and cholecystokinin [146].  
Lou et al. also reported that EA can significantly reduce leptin levels and increase 
adiponectin serum levels in obese [147]. Finally, study of Fan et al. evidenced that EA at 
lateral Housanli and Neiting (ST44) with 2-15 Hz, 4mA for 49 days, was more effective 
than the anti-obesity drug, sibutramine, to reduce body mass through the regulation of 
adiponectin and insulin levels inobese rats [148].  
To confirm that EA, and not the stress produced by the manipulation, was responsible 
for body weight reduction and adipokines modulation, Kim et al. compared three groups 
of rats: AL (fed ad libitum without any treatment), Holder (fed ad libitum with daily 
holder restraint) and EA (fed ad libitum with daily holder restraint and 100 Hz EA 
stimulation) groups. After the four-week experimental period, they evidenced that food 
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intake and body weight reduction in EA group was associated to increased serum leptin 
levels, as previously reported. Interestingly, the level of stress hormones, such as 
epinephrine and norepinephrine, and corticosterone, was increased in Holder group, but 
not in EA group.  
Altogether, these results suggested that the effect of EA on body weight was through 
increasing leptin, but was not due to the stress caused by the daily holder restraint [149]. 
Taken altogether, these studies indicated that EA might help to control obesity owing to 
its beneficial effects on hormones that participate in pathways regulating body weight, 
namely leptin and adiponectin, among others. An interesting study showed that the 
significant reduction in food intake and body weight in DIO rats treated with 2 Hz EA 
(Zusanli (ST36) and Sanyinjiao (SP6) with intensity increasing stepwise from 0.5-1-1.5 
mA daily for 30 minutes), was associated with increased levels of α-MSH peptide and 
POMC mRNA in hypothalamus, and an elevated α-MSH concentration in CSF. These 
data suggested that the mechanism by which EA controls body weight in rat involves α-
MSH that has an anorexigenic effect [150].  
In another study, in addition to the effect on appetite and α-MSH, the of 2 Hz EA (four 
weeks, three sessions/week) in DIO rats also induced increase in anorexigenic CART 
peptide, and a decrease in orexigenic peptide NPY in hypothalamus. The modulation of 
these neuropeptides could explain the reduction of food intake and body weight in rat. 
Notably, 2 Hz EA treatment induced a more important reduction in food intake, body 
weight and ghrelin levels, that 100 Hz EA; while 100 Hz EA was more efficient to 
reduce cholesterol and triglycerides, and increase plasma leptin [151].  
Some of the studies described above showed that EA not only modulates leptin and 
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adiponectin, but also affects insulin levels.  
Cabioğlu and colleagues found that EA application (ear points Sanjiao (Hungry) and 
Shenmen (Stomach), and body points Hegu (LI4), Quchi (LI11), Tianshu (ST25), 
Zusanli (ST36), Neiting (ST44) and Taichong (LV3), once daily, for 30 minutes, during 
20 days) produced a 4.8% weight reduction and a significant decrease (p<0.05) in total 
cholesterol, triglycerides and LDL in obese women [152], as well  
as a significant decrease in lipoproteinA and apolipoprotein B (p<0.05), indicating that 
EA therapy might be a useful approach for both losing weight and reducing risk factors 
for associated cardiovascular diseases [153]. Interestingly, the effects of EA also included 
an increase in serum insulin and c-peptide levels (p<0.001) and a decrease in glucose 
levels (p<0.01), suggesting that EA can help to control serum glucose levels through 
regulation of serum insulin and c-peptide levels [154].  
Lin et al. reported that EA treatment with 15 Hz at bilateral Zusanli (ST36) was able to 
significantly reduce HOMA index from 7.29•} 3.0 to 3.3 •} 1.1 in rats with insulin 
resistance induced by prednisolone, while HOMA index was 5.1 •} 1 in control. Plasma 
levels of FFAs were significantly decreased after 60 minutes of prednisolone injection 
(until 16 •} 20% in EA group, compared with 72 •} 31% in control).Therefore, the 
positive effect of EA on insulin resistance could be by lowering plasma FFAs levels 
[155].  
Another study also demonstrated that the decrease in FFAs levels in response to 3 Hz 
EA (Zusanli (ST36) and Guanyuan (CV4), five sessions/week, eight weeks), was 
associated to up-regulation of skeletal. 
Sirtuin 1 (SIRT1) protein expression, peroxisome proliferator-actived receptor γ 
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coactivator 1α (PGC-1α), nuclear respiratory factor 1 (NRF 1) and acyl-CoA oxidase 
(ACOX).  
Authors concluded that low-frequency EA improves insulin sensibility in obese diabetic 
mice probably through activation of SIRT 1/PGC-1α in skeletal muscle [156].  
Obesity is closely associated with a chronic inflammation and a few studies have 
described the anti-inflammatory actions of acupuncture in the treatment of obesity. For 
example, results from Yu et al. evidenced that strong EA (20 Hz, 5 V at Zusanli (ST36) 
and Sanyinjiao (SP6) daily for 14 days) was more effective to regulate body weight, as 
well as triglycerides, cholesterol, HDL and LDL, than weak EA (20 Hz, 2.5 V)in obese 
rats. Interestingly, RT-PCR assays using RNA obtained from epididymis adipose tissue 
revealed a significant reduction of transcripts corresponding to that monocyte 
chemoattractant protein-1 (MCP-1) and TNFα, both proinflammatory molecules. Then 
the modulation of inflammation could contribute to the effects of EA in obese patients  
[157].Song, et al found that paraventricular subnuclei neurons were active during the 
stress condition, especially the parvocellular subnuclei. In the present experiments, we 
observed that nearly 25% (163/653) of the neurons recorded in PVN responded to the 
noxious heat stimulus (48°C), including 42 inhibitory neurons and 121 excitatory ones. 
The experiments observed the characters of neurons via the feedback regulation of 
hydrocortisone.  
The physiological characters of these neurons were similar to those of CRH neurons in 
PVN, indicating their correlationwith CRH neurons activities. These neurons are the 
target neurons in our study.  
The acupoints specifically activate SRNs in PVN were also the specificity acupoints for 
88 
 
the regulation of HPAA function.  
CRH secreted by hypothalamus are the small cell peptidergic neurons. The 
hypothalamic regulatory peptides are released into the portal system via the projection 
of the axons to the median eminence. Its axonal endings contact with the first level of 
capillary in pituitary portal system.  
These CRH neurons release regulatory peptide into the portal system. Regulating ACTH 
secretion from pituitary gland and promoting the secretion of CORT in target gland. At 
the same time, the secretion of CRH neurons in hypothalamus is regulated by the 
feedback signals and the central nerve system. The regulation of feedback signals 
includes the short-loop feedback and the long-loop feedback, representing the main type 
of regulation on CRH secretion.  
Additionally, CRH itself can produce ultra short-loop feedback for its self-regulation.  
Studies have shown that acupuncture regulated the function of HPAA via promoting 
hypothalamic CRH secretion so that ACTH and CORT secretion could be regulated . In 
order to verify the effect of specificity acupoints on regulating HPAA, we examined the 
behavior, peripheral blood CORT levels, GR and CRH protein expressions in PVN in 
UCMS model rats under acupuncture at the specificity acupoints and the nonspecificity 
acupoints. The results showed that acupuncture at specificity acupoints modulated the 
behavior in UCMS rats, down-regulated the level of CORT in peripheral blood, 
promoted GR expression and suppressed ,CRH excessive secretion in PVN as compared 
with M group. It suggests that the acupoints for the specific activation on SRNs in PVN 
are also the specificity acupoints for the regulation of HPAA function.  
Through this study it is found that acupuncture becomes one of the effective treatment 
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which helps in, reducing the anthropometric mesurements,BMI,HC,WC ,WHR and the 
possible mechanism or the proposed one behind the results are  
The hypothalamus — particularly the arcuate nucleus (ARC) — and the brain — 
particularly the nucleusof the solitary tract (NTS) — are the main sites of convergence 
and integration of the central and peripheral signals that regulate food intake and energy 
expenditure [158, 159]  
There are mechanisms of short-term regulation (satiety signals) which determine the 
beginning and end of a meal (hunger and satiation) and the interval between meals 
(satiety) [160], and long-term regulatory factors (signals of adiposity) which help the 
body to regulate energy depots. Satiety signals from the GIT are transmitted primarily 
through vagal and spinal nerves to the NTS, while the signals of adiposity reach the 
median eminence via ARC or by crossing the blood-brain barrier (BBB) through 
saturable and non-saturable mechanisms. There is, however, a large integration and 
convergence of these signals by neural connections between the ARC nucleus, NTS, 
and vagal afferent fibres.  
In recent years, the central regulation of energy balance has become even more 
fascinating and complex with the characterization of new mechanisms of control. The 
endocannabinoid system participates in energy homeostasis by central and peripheral 
actions that influence appetite, motivation for consumption of palatable food, 
production and distribution of fat, energy expenditure, and glucose and insulin 
homeostasis [161].  
These new findings on the neuroendocrine mechanisms controlling energy homeostasis 
and body weight show the complexity of these integrating systems and the existence of 
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many unravelled mysteries.  
Nevertheless, each mystery unveiled opens new opportunities for the development of 
novel therapies for obesity and nutritional disorders [162].  
This study is limited as the study design was not suitable and the sample size is small. 
As a future study this can be repeated in all grades of obesed individuals with the larger 
sample size and for a longer duration. 
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 CONCLUSION 
 There were noteworthy improvements, positive reduction of weight in obesed 
individuals, waist hip ratio got significant reduction after acupuncture in the 
obesed individuals.  
  Through this study, Acupuncture plays an inevitable role in weight reduction 
through enhanced fat metabolism and prevention of fat deposition, which would 
be of utmost importance in effective weight reduction in case of obesity by 
improving spleen function.  
 Also by improving spleen function it influences the psychological well being of 
the obesed individuals as self esteemed reflecting in the improved quality of life.  
  Acupuncture, being an effective therapy for improving spleen function in spleen 
energy deficient obesed individuals.  
  Hence Acupuncture influences the individual`s quality of life and weight 
management positively making it an evidence based treatment for obesed 
individuals of spleen energy deficiency.  
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ANNEXURE 
PROFORMA 
Name:                                           Age:     yrs        Gender: Male / Female                                                           
Occupation:    Marital Status: Religion:                                                                              
Address: 
Emergency Contact:                                                      
Primary Language(s):  
Complaints: 
 
History of present Illness: 
Previous Illness: 
Personal History: 
 
 
 
 
 
Bowel: 
Coffee/Tea: 
Micturition: 
with/without sugar 
Addiction
: Diet    : 
 
Family History: 
  
 
 
  
 
History of Allergy to any specific drugs/food,if any: 
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Obstetrics & Gynaecology history:  
 
Vital data: 
Built:     BMI:     Waist Hip ratio: 
Height: cms   Weight:  kgs 
Pulse:               beats/min  Blood Pressure: mm/Hg 
Temperature:  
GENERAL PHYSICAL EXAMINATION: 
SYSTEMIC 
EXAMINATION: 
Cardiovascular System: 
Respiratory System: 
Abdomen: 
Nervous System: 
Endocrine System: 
Genitourinary System: 
Locomotor System: 
Investigation 
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  SPLEEN  QUESTIONAIRE 
 
 Subjects were given a set of spleen qi deficiency questionnaires for scoring. (one 
question- 1 score)  
1. Edema : yes / no  
2. Lassitude : yes / no  
3. Heavy sensation in the body : yes / no  
4. Oliguria : yes / no  
5. Anorexia : yes / no  
6. Abdominal fullness : yes / no  
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   INFORMED CONSENT FORM  
Title of the study : “EVALUATION OF EFFECT OF CLASSICAL ACUPUNCTURE 
ON OBESE INDIVIDUALS WITH SPLEEN ENERGY DEFICIENCY”  
Name of the Participant :  
Name of the Principal Investigator : Dr.B.Narmada devi  
Name of the Institution : Government Yoga & Naturopathy Medical  
College, Chennai – 600 106  
Documentation of the informed consent  
I _____________________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am over 
18 years of age and, exercising my free power of choice, hereby give my consent to be 
included as a participant in  
1. I have read and understood this consent form and the information provided to me.  
2. I have had the consent document explained to me.  
3. I have been explained about the nature of the study.  
4. I have been explained about my rights and responsibilities by the investigator.  
5. I have been informed the investigator of all the treatments I am taking or have taken in 
the past ________ months including any native (alternative) treatment.  
6. I have been advised about the risks associated with my participation in this study.  
7. I agree to cooperate with the investigator and I will inform him/her immediately if I 
suffer unusual symptoms.  
8. I have not participated in any research study within the past _________month(s).  
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9. I am aware of the fact that I can opt out of the study at any time without having to give 
any reason and this will not affect my future treatment in this hospital.  
10. I am also aware that the investigator may terminate my participation in the study at 
any time, for any reason, without my consent.  
12. I hereby give permission to the investigators to release the information obtained from 
me as result of participation in this study to the sponsors, regulatory authorities, Govt. 
agencies, and IEC. I understand that they are publicly presented.  
13. I have understood that my identity will be kept confidential if my data are publicly 
presented.  
14. I have had my questions answered to my satisfaction.  
15. I have decided to be in the research study.  
I am aware that if I have any question during this study, I should contact the investigator. 
By signing this consent form I attest that the information given in this document has been 
clearly explained to me and understood by me, I will be given a copy of this consent 
document.  
For adult participants:  
Name and signature / thumb impression of the participant (or legal representative if 
participant incompetent)  
Name _________________________ Signature_________________  
Date________________  
Name and Signature of impartial witness (required for illiterate patients):  
Name _________________________ Signature_________________  
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Date________________  
Address and contact number of the impartial witness:  
Name and Signature of the investigator or his representative obtaining consent:  
Name _________________________ Signature_________________  
Date________________  
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INFORMATION TO PARTICIPANTS  
Investigator: Dr.B.Narmada devi  
Name of Participant:  
Title: “EVALUATION OF EFFECT OF CLASSICAL ACUPUNCTURE ON OBESE 
INDIVIDUALS WITH SPLEEN ENERGY DEFICIENCY”  
You are invited to take part in this research/ study /procedures. The information in this 
document is meant to help you decide whether to take part. Please feel free to ask if you 
have any queries or concerns.  
You are being asked to participate in this study being conducted in Government Yoga 
and Naturopathy Medical College, Chennai.  
What is the Purpose of the Research?  
To evaluate the effect of classical acupuncture in obese individuals.  
The Study Design  
Thirty individuals both male or female with obesity will participate in the study.  
Study Procedures  
The study involves needling specific selected points for the selected subjects during the 
three days in a week for three months.  
Possible Risks to you - Nil  
Possible Benefits to you- Changes in the anthropometric measurements seen .  
Possible benefits to other people The result of the research may provide benefits to the 
society in terms of use of acupuncture as an alternative approach to obesity instead of 
taking drugs and medicines. Improvement in their appetite is seen  
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Confidentiality of the information obtained from you  
You have the right to confidentiality regarding the privacy of your medical information 
(personal details, results of physical examinations, investigations, and your medical 
history). By signing this document, you will be allowing the research team investigators, 
other study personnel, sponsors, IEC and any person or agency required by law like the 
Drug Controller General of India to view your data, if required.  
The information from this study, if published in scientific journals or presented at 
scientific meetings, will not reveal your identity.  
How will your decision to not participate in the study affect you?  
Your decisions to not to participate in this research study will not affect your medical 
care or your relationship with investigator or the institution. Your doctor will still take 
care of you and you will not lose any benefits to which you are entitled.  
Can you decide to stop participating in the study once you start?  
The participation in this research is purely voluntary and you have the right to withdraw 
from this study at any time during course of the study without giving any reasons.  
However, it is advisable that you talk to the research team prior to stopping the treatment 
 
 
 
